Fármacos, Tratamento Covid e Vacina


Ruxolitinib for tocilizumab-refractory severe COVID-19 infection

Innes AJ, Cook LB, Marks S, Bataillard E, Crossette-Thambiah C, Sivasubramaniam G, Apperley J, Milojkovic D.

Abstract:

Link para artigo

Convalescent plasma for persisting Covid-19 following therapeutic lymphocyte depletion: a report of rapid recovery

Clark E, Guilpain P, Filip L, Pansu N, Le Bihan C, Cartron G, Tchernonog E, Roubille C, Morquin D, Makinson A, Tuaillon E, Le Moing V.

Abstract:

Link para artigo

Attenuation of antibody response to SARS-CoV-2 in a patient on ocrelizumab with hypogammaglobulinemia

Conte WL.

Abstract:

Link para artigo

Helping doctors hasten COVID-19 treatment: Towards a rescue framework for the transfusion of best convalescent plasma to the most critical patients based on biological requirements via ml and novel MCDM methods

Albahri OS, Al-Obaidi JR, Zaidan AA, Albahri AS, Zaidan BB, Salih MM, Qays A, Dawood KA, Mohammed RT, Abdulkareem KH, Aleesa AM, Alamoodi AH, Chyad MA, Zulkifli CZ.

Abstract:

Link para artigo

Does PDT have potential in the treatment of COVID 19 patients?

Moghissi K, Dixon K, Gibbins S.

Abstract:

Link para artigo

Emerging vaccine delivery systems for COVID-19: Functionalised silica nanoparticles offer a potentially safe and effective alternative delivery system for DNA/RNA vaccines and may be useful in the hunt for a COVID-19 vaccine

Theobald N.

Abstract:

Link para artigo

A proposed mechanism for the possible therapeutic potential of Metformin in COVID-19

Esam Z.

Abstract:

Link para artigo

Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection

Li C, Wang L, Ren L.

Abstract:

Link para artigo

Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome?

Bailly C, Vergoten G.

Abstract:

Link para artigo

Retrospective, multicenter study on the impact of baricitinib in COVID-19 moderate pneumonia

Cantini F, Niccoli L, Nannini C, Matarrese D, Natale MED, Lotti P, Aquilini D, Landini G, Cimolato B, Pietro MAD, Trezzi M, Stobbione P, Frausini G, Navarra A, Nicastri E, Sotgiu G, Goletti D.

Abstract:

Link para artigo

In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19

Zhang XJ, Qin JJ, Cheng X, Shen L, Zhao YC, Yuan Y, Lei F, Chen MM, Yang H, Bai L, Song X, Lin L, Xia M, Zhou F, Zhou J, She ZG, Zhu L, Ma X, Xu Q, Ye P, Chen G, Liu L, Mao W, Yan Y, Xiao B, Lu Z, Peng G, Liu M, Yang J, Yang L, Zhang C, Lu H, Xia X, Wang D, Liao X, Wei X, Zhang BH, Zhang X, Yang J, Zhao GN, Zhang P, Liu PP, Loomba R, Ji YX, Xia J, Wang Y, Cai J, Guo J, Li H.

Abstract:

Link para artigo

Hydroxychloroquine, COVID-19 and diabetes. Why it is a different story

Stoian AP, Catrinoiu D, Rizzo M, Ceriello A.

Abstract:

Link para artigo

The challenging pathway towards the identification of SARS-CoV-2/COVID-19 therapeutics

Siccardi M, Schapiro J, Di Perri G, Back DJ.

Abstract:

Link para artigo

Are hydroxychloroquine and chloroquine effective in the treatment of SARS-COV-2 (COVID-19)?

Wright C, Ross C, Mc Goldrick N.

Abstract:

Link para artigo

SARS-CoV-2 vaccines: 'Warp Speed' needs mind melds not warped minds

Moore JP, Klasse PJ.

Abstract:

Link para artigo

Is the production of a Covid-19 vaccine using transformed Pasteurella plausible?

Rycroft AN, Smith KC, Noad R, Werling D.

Abstract:

Link para artigo

Clinical course and outcome of COVID-19 in patients with rheumatic diseases: are all biological disease-modifying antirheumatic drugs alike? Response to: 'Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab' by Schulze-Koops et al

Monti S, Montecucco C.

Abstract:

Link para artigo

Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab

Schulze-Koops H, Krueger K, Vallbracht I, Hasseli R, Skapenko A.

Abstract:

Link para artigo

Supportive treatment of COVID 19 patients with mild respiratory failure in a primary hospital

Martín Raymondi D, Hernández L.

Abstract:

Link para artigo

Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: Safety algorithm

Valero-López G, Carreón-Guarnizo E, Hernández-Clares R, Iniesta-Martínez F, Jiménez-Veiga J, Moreno-Docon A, Iborra-Bendicho MA, Morales-Ortiz A, Meca-Lallana JE.

Abstract:

Link para artigo

ACTH 1-24 and other melanocortins for COVID-19 treatment

Bertolini A, Noera G.

Abstract:

Link para artigo

Remdesivir Receives Emergency Use Authorization for Severely Ill Patients with COVID-19

Aschenbrenner DS.

Abstract:

Link para artigo

Nitric Oxide dosed in short bursts at high concentrations may protect against Covid 19

Hedenstierna G, Chen L, Hedenstierna M, Lieberman R, Fine DH.

Abstract:

Link para artigo

The database-based strategy may overstate the potential effects of traditional Chinese medicine against COVID-19

Huang YX, Wang WX, Zhang S, Tang YP, Yue SJ.

Abstract:

Link para artigo

Safety, Tolerability, and Pharmacokinetics of Remdesivir, an Antiviral for Treatment of COVID-19, in Healthy Subjects

Humeniuk R, Mathias A, Cao H, Osinusi A, Shen G, Chng E, Ling J, Vu A, German P.

Abstract:

Link para artigo

Immunosuppression drug advice and COVID-19: are we doing more harm than good?

Warraich R, Amani L, Mediwake R, Tahir H.

Abstract:

Link para artigo

Current State of Research About Chinese Herbal Medicines (CHM) for the Treatment of Coronavirus Disease 2019 (COVID-19): A Scoping Review

López-Alcalde J, Yan Y, Witt CM, Barth J.

Abstract:

Link para artigo

SARS-CoV-2 and HIV protease inhibitors: why lopinavir/ritonavir will not work for COVID-19 infection

Smolders EJ, Te Brake LH, Burger DM.

Abstract:

Link para artigo

Statistical Issues and Lessons Learned from COVID-19 Clinical Trials with Lopinavir-Ritonavir and Remdesivir

Yin G, Zhang C, Jin H.

Abstract:

Link para artigo

Vesicular drug-delivery systems as theranostics in COVID-19

Satija S, Mehta M, Sharma M, Prasher P, Gupta G, Chellappan DK, Dua K.

Abstract:

Link para artigo

High-dose but not low-dose corticosteroids potentially delay viral shedding of patients with COVID-19

Li S, Hu Z, Song X.

Abstract:

Link para artigo

QT interval prolongation under hydroxychloroquine/ azithromycin association for inpatients with SARS-CoV-2 lower respiratory tract infection

Bun SS, Taghji P, Courjon J, Squara F, Scarlatti D, Theodore G, Baudouy D, Sartre B, Labbaoui M, Dellamonica J, Doyen D, Marquette CH, Levraut J, Esnault V, Bun SS, Ferrari E.

Abstract:

Link para artigo

Corticosteroids in diabetes patients infected with COVID-19

Deng F, Gao D, Ma X, Guo Y, Wang R, Jiang W, Gong S.

Abstract:

Link para artigo

Comment on "Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?"

Cure E, Cumhur Cure M, Kucuk A.

Abstract:

Link para artigo

COVID-19 in dimethyl fumarate-treated patients with multiple sclerosis

Mantero V, Abate L, Basilico P, Balgera R, Salmaggi A, Nourbakhsh B, Cordano C.

Abstract:

Link para artigo

First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe COVID-19 Pneumonia

Temesgen Z, Assi M, Vergidis P, Rizza SA, Bauer PR, Pickering BW, Razonable RR, Libertin CR, Burger CD, Orenstein R, Vargas HE, Varatharaj Palraj BR, Dababneh AS, Chappell G, Chappell D, Ahmed O, Sakemura R, Durrant C, Kenderian SS, Badley A.

Abstract:

Link para artigo

A potential role for Galectin-3 inhibitors in the treatment of COVID-19

Caniglia JL, Guda MR, Asuthkar S, Tsung AJ, Velpula KK.

Abstract:

Link para artigo

Extending rituximab dosing intervals in patients with MS during the COVID-19 pandemic and beyond?

Maarouf A, Rico A, Boutiere C, Perriguey M, Demortiere S, Pelletier J, Audoin B; Under the aegis of OFSEP.

Abstract:

Link para artigo

Inhibition of SARS-CoV-2 by type I and type III interferons

Felgenhauer U, Schoen A, Gad HH, Hartmann R, Schaubmar AR, Failing K, Drosten C, Weber F.

Abstract:

Link para artigo

COvid MEdicaTion (COMET) study: protocol for a cohort study

Sablerolles RSG, Hogenhuis FEF, Lafeber M, van de Loo BPA, Borgsteede SD, Boersma E, Versmissen J, van der Kuy HM; COMET Research team.

Abstract:

Link para artigo

Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors

Jovani V, Calabuig I, Peral-Garrido ML, Tovar-Sugrañes E, López-González MD, Bernabeu P, Martínez A, Esteve-Vives J, León-Ramírez JM, Moreno-Perez O, Boix V, Gil J, Merino E, Vela P, Andrés M.

Abstract:

Link para artigo

Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments

Gendebien Z, von Frenckell C, Ribbens C, André B, Thys M, Gangolf M, Seidel L, Malaise MG, Malaise O.

Abstract:

Link para artigo

Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics

Mendel A, Bernatsky S, Askanase A, Bae SC, Clarke AE, Costedoat-Chalumeau N, Gladman DD, Gordon C, Hanly J, Jacobsen S, Kalunian K, Mak A, Mosca M, Pons-Estel BA, Ruiz-Irastorza G, Urowitz M, Vinet É.

Abstract:

Link para artigo

Triiodothyronine for the treatment of critically ill patients with COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial

Pantos C, Kostopanagiotou G, Armaganidis A, Trikas A, Tseti I, Mourouzis I.

Abstract:

Link para artigo

A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial"

Tornero C, Vallejo R, Cedeño D, Orduña J, Pastor E, Belaouchi M, Escamilla B, Laredo M, Del Mar Garzando M.

Abstract:

Link para artigo

Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol

Marietta M, Vandelli P, Mighali P, Vicini R, Coluccio V, D'Amico R; COVID-19 HD Study Group.

Abstract:

Link para artigo

Advanced bioinformatics rapidly identifies existing therapeutics for patients with coronavirus disease-2019 (COVID-19)

Kim J, Zhang J, Cha Y, Kolitz S, Funt J, Escalante Chong R, Barrett S, Kusko R, Zeskind B, Kaufman H.

Abstract:

Link para artigo

Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: a structured summary of a study protocol for a randomised controlled trial

Allahyari A, Rahimi H, Khadem-Rezaiyan M, Mozaheb Z, Seddigh-Shamsi M, Bary A, Kamandi M, Azimi SA, HasanAbadi SE, Noferesti A, Shariatmaghani SS, Rafatpanah H, Khatami S, Imani AJ, Mortazi H, Nodeh MM.

Abstract:

Link para artigo

A prospect on the use of antiviral drugs to control local outbreaks of COVID-19

Torneri A, Libin P, Vanderlocht J, Vandamme AM, Neyts J, Hens N.

Abstract:

Link para artigo

The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications

McFadyen JD, Stevens H, Peter K.

Abstract:

Link para artigo

Montelukast's ability to fight COVID-19 infection

Bozek A, Winterstein J.

Abstract:

Link para artigo

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries

Elshabrawy HA.

Abstract:

Link para artigo

Emerging Prevention and Treatment Strategies to Control COVID-19

Singh VK, Mishra A, Singh S, Kumar P, Singh M, Jagannath C, Khan A.

Abstract:

Link para artigo

A Case of Successful Treatment of Severe COVID-19 Pneumonia with Favipiravir and Tocilizumab in Post-kidney Transplant Recipient

Thammathiwat T, Tungsanga S, Tiankanon K, Torvorapanit P, Chumpangern W, Udomkarnjananun S, Avihingsanon Y, Sriprasart T, Srisawat N, Jutivorakool K, Paitoonpong L, Putcharoen O, Townamchai N.

Abstract:

Link para artigo

Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses

Gupta T, Gupta SK.

Abstract:

Link para artigo

Immune-related pneumonitis with nivolumab and ipilimumab during the coronavirus disease 2019 (COVID-19) pandemic

Souza IL, Fernandes Í, Taranto P, Buzaid AC, Schvartsman G.

Abstract:

Link para artigo

Optical theranostics and treatment dosimetry for COVID-19 lung complications: towards increasing the survival rate of vulnerable populations

Nogueira MS.

Abstract:

Link para artigo

Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment

Yeleswaram S, Smith P, Burn T, Covington M, Juvekar A, Li Y, Squier P, Langmuir P.

Abstract:

Link para artigo

Therapeutic Plasma Exchange in Adults with Severe COVID-19 Infection

Khamis F, Al-Zakwani I, Al Hashmi S, Al Dowaiki S, Al Bahrani M, Pandak N, Al Khalili H, Memish Z.

Abstract:

Link para artigo

Convalescent plasma therapy in the treatment of COVID-19: some considerations: correspondence

Wiwanitkit V.

Abstract:

Link para artigo

Use of inhaled corticosteroids in asthma and COVID-19 : Keep calm and carry on

Lipworth B, Chan R, RuiWen Kuo C.

Abstract:

Link para artigo

Use of aerosolised medications at home for COVID-19

Ari A.

Abstract:

Link para artigo

THE RIGHT TIME FOR STEROIDS IN COVID-19

Cruz AF, Ruiz-Antorán B, Múñez Rubio E, López AS, Callejas Díaz A, Avendaño-Solá C, Martínez AR.

Abstract:

Link para artigo

[Rationales for using JAK 1/2 inhibitors in severely afflicted patients with COVID-19 pneumonia]

Hasselbalch HC, Poulsen A, Skov V, Kjær L, Nielsen CH, Poulsen TD.

Abstract:

Link para artigo

Clozapine and COVID-19: The authors respond

Siskind D, Honer WG, Clark S, Correll CU, Hasan A, Howes O, Kane JM, Kelly DL, Laitman R, Lee J, MacCabe JH, Myles N, Nielsen J, Schulte PF, Taylor D, Verdoux H, Wheeler A, Freudenreich O.

Abstract:

Link para artigo

Clozapine and COVID-19

Remington G, Powell V.

Abstract:

Link para artigo

A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19

Malek Mahdavi A.

Abstract:

Link para artigo

Colchicin Treatment of Covid-19 Presenting With Cutaneous Rash and Myopericarditis

Recalcati S, Piconi S, Franzetti M, Barbagallo T, Prestinari F, Fantini F.

Abstract:

Link para artigo

Combined IL-6 and JAK-STAT inhibition therapy in COVID-19 related sHLH, potential game changer

Portsmore S, Tran Nguyen TN, Beacham E, Neelakantan P.

Abstract:

Link para artigo

Successful remission induction therapy with gilteritinib in a patient with de novo FLT3-mutated acute myeloid leukaemia and severe COVID-19

Wilson AJ, Troy-Barnes E, Subhan M, Clark F, Gupta R, Fielding AK, Kottaridis P, Mansour MR, O'Nions J, Payne E, Chavda N, Baker R, Thomson K, Khwaja A.

Abstract:

Link para artigo

INFUSION OF CONVALESCENT PLASMA IS ASSOCIATED WITH CLINICAL IMPROVEMENT IN CRITICALLY ILL PATIENTS WITH COVID-19: A PILOT STUDY

Olivares-Gazca JC, Priesca-Marín JM, Ojeda-Laguna M, Garces-Eisele J, Soto-Olvera S, Palacios-Alonso A, Izquierdo-Vega J, Chacon-Cano R, Arizpe-Bravo D, López-Trujillo MA, Cantero-Fortiz Y, Fernandez-Lara D, Ruiz-Delgado GJ, Ruiz-Argüelles GJ.

Abstract:

Link para artigo

Empiric Therapies for COVID-19: Destined to Fail by Ignoring the Lessons of History

Canfield GS, Schultz JS, Windham S, Scherger S, Henao-Martinez AF, Shapiro L, Franco-Paredes C, Chastain DB, Wand T, Krsak M.

Abstract:

Link para artigo

Response to "Does amantadine have a protective effect against COVID-19?"

Tipton PW, Wszolek ZK.

Abstract:

Link para artigo

Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases

Tsuchiya A, Takeuchi S, Iwasawa T, Kumagai M, Sato T, Motegi S, Ishii Y, Koseki Y, Tomiyoshi K, Natsui K, Takeda N, Yoshida Y, Yamazaki F, Kojima Y, Watanabe Y, Kimura N, Tominaga K, Kamimura H, Takamura M, Terai S.

Abstract:

Link para artigo

Herbs that might be effective for the management of COVID-19: A bioinformatics analysis on anti-tyrosine kinase property

Sriwijitalai W, Wiwanitkit V.

Abstract:

Link para artigo

Could Coronavirus Disease 2019 (COVID-19) Render Natural Immunity to Re-infections? A Spotlight on the Therapeutic Pipeline

Abid MA, Nunley L, Abid MB.

Abstract:

Link para artigo

Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study

Giudice V, Pagliano P, Vatrella A, Masullo A, Poto S, Polverino BM, Gammaldi R, Maglio A, Sellitto C, Vitale C, Serio B, Cuffa B, Borrelli A, Vecchione C, Filippelli A, Selleri C.

Abstract:

Link para artigo

Repositioning Chromones for Early Anti-inflammatory Treatment of COVID-19

Sestili P, Stocchi V.

Abstract:

Link para artigo

Shenhuang granule in the treatment of severe coronavirus disease 2019 (COVID-19): study protocol for an open-label randomized controlled clinical trial

Fang B, Zhang W, Wu X, Huang T, Li H, Zheng Y, Che J, Sun S, Jiang C, Zhou S, Feng J.

Abstract:

Link para artigo

Evaluation on different non-pharmaceutical interventions during COVID-19 pandemic: an analysis of 139 countries

Wong M, Huang J, Teoh J, Wong S.

Abstract:

Link para artigo

Validity of the UK Early Access to Medicines Scheme Criteria for Remdesivir use in patients with COVID-19 disease

Daunt A, Perez-Guzman PN, Liew F, Hauck K, Costelloe CE, Thursz MR, Cooke G, Nayagam S.

Abstract:

Link para artigo

Integrating Telemedicine for Medication Treatment for Opioid Use Disorder in Rural Primary Care: Beyond the COVID Pandemic

Hser YI, Mooney LJ.

Abstract:

Link para artigo

Clinical pharmacology considerations for developing small molecule treatments for COVID-19

Brunsdon P, Saluja B, Sahajwalla C.

Abstract:

Link para artigo

Response to: Can Transdermal Photobiomodulation Help Us at the Time of COVID-19?

Ferreira MVL.

Abstract:

Link para artigo

Author's Response to Ferreira: Can Transdermal Photobiomodulation Help Us at the Time of COVID-19? An Update

Camacho AD.

Abstract:

Link para artigo

Clinical and biological data on the use of hydroxychloroquine against SARS-CoV-2 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease

Lucchesi A, Silimbani P, Musuraca G, Cerchione C, Martinelli G, Di Carlo P, Napolitano M.

Abstract:

Link para artigo

Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial

Deftereos SG, Giannopoulos G, Vrachatis DA, Siasos GD, Giotaki SG, Gargalianos P, Metallidis S, Sianos G, Baltagiannis S, Panagopoulos P, Dolianitis K, Randou E, Syrigos K, Kotanidou A, Koulouris NG, Milionis H, Sipsas N, Gogos C, Tsoukalas G, Olympios CD, Tsagalou E, Migdalis I, Gerakari S, Angelidis C, Alexopoulos D, Davlouros P, Hahalis G, Kanonidis I, Katritsis D, Kolettis T, Manolis AS, Michalis L, Naka KK, Pyrgakis VN, Toutouzas KP, Triposkiadis F, Tsioufis K, Vavouranakis E, Martinèz-Dol

Abstract:

Link para artigo

Colchicine for the Treatment of Myocardial Injury in Patients With Coronavirus Disease 2019 (COVID-19)-An Old Drug With New Life?

Rabbani AB, Parikh RV, Rafique AM.

Abstract:

Link para artigo

Screening of Chloroquine, Hydroxychloroquine and its derivatives for their binding affinity to multiple SARS-CoV-2 protein drug targets

Nimgampalle M, Devanathan V, Saxena A.

Abstract:

Link para artigo

Is there any supportive evidence for low dose radiotherapy for COVID-19 pneumonia?

Salomaa S, Bouffler SD, Atkinson MJ, Cardis E, Hamada N.

Abstract:

Link para artigo

COVID-19 Phenotypes and Potential Harm of Conventional Treatments: How to Prove the Hypothesis

Fowler AJ, Wan YI, Carenzo L, Haines RW.

Abstract:

Link para artigo

Meditation and Yoga Practices as Potential Adjunctive Treatment of SARS-CoV-2 Infection and COVID-19: A Brief Overview of Key Subjects

Bushell W, Castle R, Williams MA, Brouwer KC, Tanzi RE, Chopra D, Mills PJ.

Abstract:

Link para artigo

Treatment of COVID-19 by Inhaled NO to Reduce Shunt?

Hedenstierna G, Chen L, Hedenstierna M, Scaramuzzo G.

Abstract:

Link para artigo

Clinical research protocol to evaluate the effectiveness and safety of individualized homeopathic medicine in the treatment and prevention of the COVID-19 epidemic

Teixeira MZ.

Abstract:

Link para artigo

Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment

Osborne V, Davies M, Lane S, Evans A, Denyer J, Dhanda S, Roy D, Shakir S.

Abstract:

Link para artigo

G6PD variant distribution in sub-Saharan Africa and potential risks of using chloroquine/hydroxychloroquine based treatments for COVID-19

da Rocha J, Othman H, Tiemessen CT, Botha G, Ramsay M, Masimirembwa C, Adebamowo C, Choudhury A, Brandenburg JT, Matshaba M, Simo G, Gamo FJ, Hazelhurst S.

Abstract:

Link para artigo

Multicenter point-prevalence evaluation of the utilization and safety of drug therapies for COVID-19

Rhodes NJ, Dairem A, Moore W, Shah A, Postelnick MJ, Badowski ME, Michienzi SM, Borkowski JL, Polisetty RS, Fong K, Spivek ES, Beardsley JR, Hale CM, Pallotta AM, Srinivas P, Schulz LT.

Abstract:

Link para artigo

Tocilizumab for treatment of mechanically ventilated patients with COVID-19

Somers EC, Eschenauer GA, Troost JP, Golob JL, Gandhi TN, Wang L, Zhou N, Petty LA, Baang JH, Dillman NO, Frame D, Gregg KS, Kaul DR, Nagel J, Patel TS, Zhou S, Lauring AS, Hanauer DA, Martin E, Sharma P, Fung CM, Pogue JM.

Abstract:

Link para artigo

Improving Precision and Power in Randomized Trials for COVID-19 Treatments Using Covariate Adjustment, for Binary, Ordinal, and Time-to-Event Outcomes

Benkeser D, Diaz I, Luedtke A, Segal J, Scharfstein D, Rosenblum M.

Abstract:

Link para artigo

Hydroxychloroquine Proves Ineffective in Hamsters and Macaques Infected with SARS-CoV-2

Rosenke K, Jarvis MA, Feldmann F, Schwarz B, Okumura A, Lovaglio J, Saturday G, Hanley PW, Meade-White K, Williamson BN, Hansen F, Perez-Perez L, Leventhal S, Tang-Huau TL, Nason M, Callison J, Haddock E, Scott D, Sewell G, Bosio CM, Hawman D, de Wit E, Feldmann H.

Abstract:

Link para artigo

Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assay

Hanson QM, Wilson KM, Shen M, Itkin Z, Eastman RT, Shinn P, Hall MD.

Abstract:

Link para artigo

COVID-19: A Review of Emerging Preventative Vaccines and Treatment Strategies

Khan K, Dimtri F, Vargas C, Surani S.

Abstract:

Link para artigo

GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches

Lang FM, Lee KM, Teijaro JR, Becher B, Hamilton JA.

Abstract:

Link para artigo

DREAM-in-CDM Approach and Identification of a New Generation of Anti-inflammatory Drugs Targeting mPGES-1

Zhou S, Zhou Z, Ding K, Yuan Y, Loftin C, Zheng F, Zhan CG.

Abstract:

Link para artigo

Peptide Receptor Radionuclide Therapy (PRRT) during the COVID-19 pandemic: are there any concerns?

Bodei L, Bergsland EK, de Herder WK, Ferone D, Hicks RJ, Hope TA, Kunikowska JA, Pavel M, Reidy-Lagunes DL, Siveke J, Strosberg JR, Dittmer U, Herrmann K.

Abstract:

Link para artigo

Actions required to assure continuous supply of anti-rheumatic medication during the SARS-CoV-2/COVID-19 pandemic. Response to: 'Treatment adherence behaviours in rheumatic diseases during pandemic COVID-19: a Latin American experience' by Pineda-Sic et al

Schulze-Koops H, Krueger K, Specker C; Kommission Pharmakotherapie of the German Society of Rheumatology.

Abstract:

Link para artigo

Covid-19: Demand for dexamethasone surges as RECOVERY trial publishes preprint

Mahase E.

Abstract:

Link para artigo

Impact of the COVID-19 Pandemic on Immunomodulatory and Immunosuppressive Therapies in Dermatology: Patient and Physician Attitudes in Argentina

Zimman S, Cura MJ, Luna PC, Echeverría CM, Mazzuoccolo LD.

Abstract:

Link para artigo

Opioids/cannabinoids as a potential therapeutic approach in COVID-19 patients

Tahamtan A, Tavakoli-Yaraki M, Salimi V.

Abstract:

Link para artigo

COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection

Lechowicz K, Drożdżal S, Machaj F, Rosik J, Szostak B, Zegan-Barańska M, Biernawska J, Dabrowski W, Rotter I, Kotfis K.

Abstract:

Link para artigo

Merit of an Ursodeoxycholic Acid Clinical Trial in COVID-19 Patients

Subramanian S, Iles T, Ikramuddin S, Steer CJ.

Abstract:

Link para artigo

Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia

Jordan SC, Zakowski P, Tran HP, Smith EA, Gaultier C, Marks G, Zabner R, Lowenstein H, Oft J, Bluen B, Le C, Shane R, Ammerman N, Vo A, Chen P, Kumar S, Toyoda M, Ge S, Huang E.

Abstract:

Link para artigo

Making treatment recommendations during the COVID-19 pandemic

Lewin W.

Abstract:

Link para artigo

Pirfenidone: A novel hypothetical treatment for COVID-19

Seifirad S.

Abstract:

Link para artigo

Verapamil as treatment for refractory status epilepticus secondary to PRES syndrome on a SARS-Cov-2 infected patient

Gómez-Enjuto S, Hernando-Requejo V, Lapeña-Motilva J, Ogando-Durán G, Fouz-Ruiz D, Domingo-García J, Rodríguez-García E, Cemillán-Fernández CA.

Abstract:

Link para artigo

Current and future therapeutical approaches for COVID-19

Duan Y, Yao Y, Kumar SA, Zhu HL, Chang J.

Abstract:

Link para artigo

Adherence of infusible biologics during the time of COVID-19 among patients with Inflammatory Bowel Disease: A nationwide VA cohort study

Khan N, Patel D, Xie D, Pernes T, Lewis J, Yang YX.

Abstract:

Link para artigo

UHMS Position Statement: Hyperbaric Oxygen (HBO2) for COVID-19 Patients

Abstract:

Link para artigo

Hyperbaric oxygen therapy may be effective to improve hypoxemia in patients with severe COVID-2019 pneumonia: two case reports

Guo D, Pan S, Wang M, Guo Y.

Abstract:

Link para artigo

Hyperbaric oxygen as a treatment for COVID-19 infection?

Moon RD, Weaver LK.

Abstract:

Link para artigo

A sugar-coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan therapeutic and a potential vaccine for CoViD-19: An Editorial Highlight for "Selective inhibition of anti-MAG IgM autoantibody binding to myelin by an antigen specific glycopolymer"on https://doi.

Steinman L.

Abstract:

Link para artigo

Guideline-Based Chinese Herbal Medicine Treatment Plus Standard Care for Severe Coronavirus Disease 2019 (G-CHAMPS): Evidence From China

Ye YA; G-CHAMPS Collaborative Group.

Abstract:

Link para artigo

Case Report: Clinical Treatment of the First Critical Patient With Coronavirus Disease (COVID-19) in Liaocheng, Shandong Province

Tian H, Sui Y, Tian S, Zou X, Xu Z, He H, Wu T.

Abstract:

Link para artigo

Three Novel COVID-19 Pneumonia Cases Successfully Treated With Lopinavir/Ritonavir

Wada T, Shimode K, Hoshiyama T, Takayama Y, Yamaoka K.

Abstract:

Link para artigo

Doxycycline: From Ocular Rosacea to COVID-19 Anosmia. New Insight Into the Coronavirus Outbreak

Bonzano C, Borroni D, Lancia A, Bonzano E.

Abstract:

Link para artigo

New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention

Guo G, Ye L, Pan K, Chen Y, Xing D, Yan K, Chen Z, Ding N, Li W, Huang H, Zhang L, Li X, Xue X.

Abstract:

Link para artigo

Can Stem Cells Beat COVID-19: Advancing Stem Cells and Extracellular Vesicles Toward Mainstream Medicine for Lung Injuries Associated With SARS-CoV-2 Infections

Chrzanowski W, Kim SY, McClements L.

Abstract:

Link para artigo

Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review

Prayuenyong P, Kasbekar AV, Baguley DM.

Abstract:

Link para artigo

Effectiveness of Arbidol for COVID-19 Prevention in Health Professionals

Yang C, Ke C, Yue D, Li W, Hu Z, Liu W, Hu S, Wang S, Liu J.

Abstract:

Link para artigo

COVID-19: Emergence, Spread, Possible Treatments, and Global Burden

Keni R, Alexander A, Nayak PG, Mudgal J, Nandakumar K.

Abstract:

Link para artigo

Using Probiotics to Flatten the Curve of Coronavirus Disease COVID-2019 Pandemic

Baud D, Dimopoulou Agri V, Gibson GR, Reid G, Giannoni E.

Abstract:

Link para artigo

Therapeutic Options for Coronavirus Disease 2019 (COVID-19) - Modulation of Type I Interferon Response as a Promising Strategy?

Mary A, Hénaut L, Schmit JL, Lanoix JP, Brazier M.

Abstract:

Link para artigo

Thalidomide-Revisited: Are COVID-19 Patients Going to Be the Latest Victims of Yet Another Theoretical Drug-Repurposing?

Khalil A, Kamar A, Nemer G.

Abstract:

Link para artigo

Symptomatic Protective Action of Glycyrrhizin (Licorice) in COVID-19 Infection?

Murck H.

Abstract:

Link para artigo

MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy

Moll G, Drzeniek N, Kamhieh-Milz J, Geissler S, Volk HD, Reinke P.

Abstract:

Link para artigo

Interferon-α2b Treatment for COVID-19

Zhou Q, Chen V, Shannon CP, Wei XS, Xiang X, Wang X, Wang ZH, Tebbutt SJ, Kollmann TR, Fish EN.

Abstract:

Link para artigo

The Novel Coronavirus COVID-19 Outbreak: Global Implications for Antimicrobial Resistance

Murray AK.

Abstract:

Link para artigo

Available Evidence and Ongoing Clinical Trials of Remdesivir: Could It Be a Promising Therapeutic Option for COVID-19?

Sisay M.

Abstract:

Link para artigo

Core Outcome Set for Clinical Trials of COVID-19 Based on Traditional Chinese and Western Medicine

Qiu R, Zhao C, Liang T, Hao X, Huang Y, Zhang X, Chen Z, Wei X, Zhao M, Zhong C, Hu J, Li M, Han S, He T, Sun Y, Chen J, Shang H.

Abstract:

Link para artigo

COVID-19 Supply Chain Considerations for Prescription Drugs in Dermatology

Egger A, Abrouk M, Brodsky M, Kirsner RS.

Abstract:

Link para artigo

Considerations of Managing Lichen Planopilaris With Hydroxychloroquine During the COVID-19 Pandemic

Dadkhahfar S, Araghi F, Tabary M, Moravvej H.

Abstract:

Link para artigo

Heart Transplant Recipient Patient with COVID-19 Treated with Tocilizumab

Mattioli M, Fustini E, Gennarini S.

Abstract:

Link para artigo

COVID-19: From pathogenesis models to the first drug trials

Brüssow H.

Abstract:

Link para artigo

Improved Clinical Symptoms and Mortality on Severe/Critical COVID-19 Patients Utilizing Convalescent Plasma Transfusion

Xia X, Li K, Wu L, Wang Z, Zhu M, Huang B, Li J, Wang Z, Wu W, Wu M, Li W, Li L, Cai Y, Bosco B, Zhong A, Liu X, Lv T, Gan Z, Chen G, Pan Y, Liu C, Zhang K, Xu X, Wang C, Wang Q.

Abstract:

Link para artigo

[Drug treatment of coronavirus disease COVID-19: evidence exists?]

Timerbulatov SV, Timerbulstov MV, Gainullina EN, Gafarova AR, Timerbulatov VM.

Abstract:

Link para artigo

Quantification of plasma remdesivir and its metabolite GS-441524 using liquid chromatography coupled to tandem mass spectrometry. Application to a Covid-19 treated patient

Alvarez JC, Moine P, Etting I, Annane D, Larabi IA.

Abstract:

Link para artigo

Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization

Klasse PJ, Moore JP.

Abstract:

Link para artigo

Biomarker variation in patients successfully treated with tocilizumab for severe coronavirus disease 2019 (COVID-19): results of a multidisciplinary collaboration

Conrozier T, Lohse A, Balblanc JC, Dussert P, Royer PY, Bossert M, Bozgan AM, Gendrin V, Charpentier A, Toko L, Badie J, Mezher C, Roux MF, Kadiane-Oussou NJ, Contreras R, Kessler J, Mazurier I, Klopfenstein T, Zayet S.

Abstract:

Link para artigo

Management of chronic rhinosinusitis with steroid nasal irrigations: a viable non-surgical alternative in the COVID-19 Era

Sweis AM, Locke TB, Douglas JE, Lin TC, Sweis BM, Civantos AM, Kennedy DW.

Abstract:

Link para artigo

The Impact of the COVID-19 "Infodemic" on Drug-Utilization Behaviors: Implications for Pharmacovigilance

Tuccori M, Convertino I, Ferraro S, Cappello E, Valdiserra G, Focosi D, Blandizzi C.

Abstract:

Link para artigo

Erratum to: Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19

Yu B, Li C, Chen P, Zhou N, Wang L, Li J, Jiang H, Wang DW.

Abstract:

Link para artigo

[Remdesivir for patients with COVID-19]

Augustin M, Hallek M, Nitschmann S.

Abstract:

Link para artigo

Literature-based review of the drugs used for the treatment of COVID-19

Venkatasubbaiah M, Dwarakanadha Reddy P, Satyanarayana SV.

Abstract:

Link para artigo

Still early to define a clear role of antimalarial drugs for COVID-19 in patients with rheumatic disease. Response to: 'Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?' by Xie et al

Gamboa-Alonso CM, Figueroa-Parra G, Galarza-Delgado DA.

Abstract:

Link para artigo

IMPACT OF GLUCOCORTICOID TREATMENT IN SARS-COV-2 INFECTION MORTALITY: A RETROSPECTIVE CONTROLLED COHORT STUDY

Fernández Cruz A, Ruiz-Antorán B, Muñoz Gómez A, Sancho López A, Mills Sánchez P, Centeno Soto GA, Blanco Alonso S, Javaloyes Garachana L, Galán Gómez A, Valencia Alijo Á, Gómez Irusta J, Payares-Herrera C, Morrás Torre I, Sánchez Chica E, Delgado Téllez de Cepeda L, Callejas Díaz A, Ramos Martínez A, Múñez Rubio E, Avendaño-Solá C; Puerta de Hierro COVID-19 Study Group.

Abstract:

Link para artigo

Oseltamivir for coronavirus illness: post-hoc exploratory analysis of an open-label, pragmatic, randomised controlled trial in European primary care from 2016 to 2018

Coenen S, van der Velden AW, Cianci D, Goossens H, Bongard E, Saville BR, Gobat N, de Paor M, Ieven M, Verheij TJ, Butler CC.

Abstract:

Link para artigo

Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab

Figuero-Pérez L, Olivares-Hernández A, Escala-Cornejo RA, Terán-Brage E, López-Gutiérrez Á, Cruz-Hernández JJ.

Abstract:

Link para artigo

The Brighton collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines

Kim D, Robertson JS, Excler JL, Condit RC, Fast PE, Gurwith M, Pavlakis G, Monath TP, Smith J, Wood D, Smith ER, Chen RT, Kochhar S; Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG).

Abstract:

Link para artigo

Amantadine Treatment for People with COVID-19

Araújo R, Aranda-Martínez JD, Aranda-Abreu GE.

Abstract:

Link para artigo

Correction to: Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial

Bosteels C, Maes B, Van Damme K, De Leeuw E, Declercq J, Delporte A, Demeyere B, Vermeersch S, Vuylsteke M, Willaert J, Bollé L, Vanbiervliet Y, Decuypere J, Libeer F, Vandecasteele S, Peene I, Lambrecht BN.

Abstract:

Link para artigo

Correction to: Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial

Maes B, Bosteels C, De Leeuw E, Declercq J, Van Damme K, Delporte A, Demeyere B, Vermeersch S, Vuylsteke M, Willaert J, Bollé L, Vanbiervliet Y, Decuypere J, Libeer F, Vandecasteele S, Peene I, Lambrecht BN.

Abstract:

Link para artigo

Correction to: Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials

Ten Doesschate T, Moorlag SJCFM, van der Vaart TW, Taks E, Debisarun P, Ten Oever J, Bleeker-Rovers CP, Verhagen PB, Lalmohamed A, Ter Heine R, van Crevel R, van de Wijgert J, Janssen AB, Bonten MJ, van Werkhoven CH, Netea MG; BCG-CORONA study team#.

Abstract:

Link para artigo

Cutaneous side effects of hydroxychloroquine in health care workers in a COVID referral hospital - implications for clinical practice

Sardana K, Mathachan SR, Deepak D, Khurana A, Sinha S.

Abstract:

Link para artigo

Nanotechnology for COVID-19: Therapeutics and Vaccine Research

Chauhan G, Madou MJ, Kalra S, Chopra V, Ghosh D, Martinez-Chapa SO.

Abstract:

Link para artigo

Short-Term Dexamethasone in Sars-CoV-2 Patients

Selvaraj V, Dapaah-Afriyie K, Finn A, Flanigan TP.

Abstract:

Link para artigo

Microbiota Modulating Nutritional Approaches to Countering the Effects of Viral Respiratory Infections Including SARS-CoV-2 through Promoting Metabolic and Immune Fitness with Probiotics and Plant Bioactives

Shinde T, Hansbro PM, Sohal SS, Dingle P, Eri R, Stanley R.

Abstract:

Link para artigo

Exportin 1 inhibition as antiviral therapy

Uddin MH, Zonder JA, Azmi AS.

Abstract:

Link para artigo

Network pharmacological approach for elucidating the mechanisms of traditional Chinese medicine in treating COVID-19 patients

Pan HD, Yao XJ, Wang WY, Lau HY, Liu L.

Abstract:

Link para artigo

COVID-19: review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking

Magro G.

Abstract:

Link para artigo

Ritonavir/Lopinavir and Its Potential Interactions With Psychiatric Medications: A COVID-19 Perspective

Mansuri Z, Shah B, Adnan M, Chaudhari G, Jolly T.

Abstract:

Link para artigo

Can artificial intelligence identify effective COVID-19 therapies?

Schultz MB, Vera D, Sinclair DA.

Abstract:

Link para artigo

Outcomes in Patients with Severe COVID-19 Disease Treated with Tocilizumab - A Case- Controlled Study

Rojas-Marte GR, Khalid M, Mukhtar O, Hashmi AT, Waheed MA, Ehrlich S, Aslam A, Siddiqui S, Agarwal C, Malyshev Y, Henriquez-Felipe C, Sharma D, Sharma S, Chukwuka N, Rodriguez DC, Alliu S, Le J, Shani J.

Abstract:

Link para artigo

Efficacy and safety of Chinese patent medicine injection for COVID-19: A protocol for systematic review and meta-analysis

Lu M, Lu Z, Zhang T, Wang W, Xue Y, Cao Z.

Abstract:

Link para artigo

Chinese medicine for COVID-19: A protocol for systematic review and meta-analysis

Chen H, Xie Z, Zhu Y, Chen Q, Xie C.

Abstract:

Link para artigo

Pharmacological development of the potential adjuvant therapeutic agents against coronavirus disease 2019

Chen KH, Wang SF, Wang SY, Yang YP, Wang ML, Chiou SH, Chang YL.

Abstract:

Link para artigo

Remdesivir (GS-5734) as a therapeutic option of 2019-nCOV main protease - in silico approach

Naik VR, Munikumar M, Ramakrishna U, Srujana M, Goudar G, Naresh P, Kumar BN, Hemalatha R.

Abstract:

Link para artigo

Tocilizumab's efficacy in COVID-19 patients is determined by the presence of cytokine storm

Andrianopoulos I, Papathanasiou A, Papathanakos G, Chaidos A, Koulouras V.

Abstract:

Link para artigo

Successful treatment of severe COVID-19 with subcutaneous anakinra as a sole treatment

González-García A, García-Sánchez I, Lopes V, Moreno-Arrones OM, Tortosa-Cabañas M, Elías-Sáenz I, Hernández-Rodríguez J.

Abstract:

Link para artigo

Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?

Thalha AMM, Lee YY, Besari A, Omar SFS.

Abstract:

Link para artigo

Emerging pharmacotherapy for COVID-19

Lipworth B, Kuo CR, Chan R.

Abstract:

Link para artigo

Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA: Position paper of the German ARIA Group(A) in cooperation with the Austrian ARIA Group(B), the Swiss ARIA Group(C), German Society for Applied Allergology (AEDA)(D), German Society for

Klimek L, Pfaar O, Worm M, Bergmann KC, Bieber T, Buhl R, Buters J, Darsow U, Keil T, Kleine-Tebbe J, Lau S, Maurer M, Merk H, Mösges R, Saloga J, Staubach P, Stute P, Rabe K, Rabe U, Vogelmeier C, Biedermann T, Jung K, Schlenter W, Ring J, Chaker A, Wehrmann W, Becker S, Mülleneisen N, Nemat K, Czech W, Wrede H, Brehler R, Fuchs T, Tomazic PV, Aberer W, Fink-Wagner A, Horak F, Wöhrl S, Niederberger-Leppin V, Pali-Schöll I, Pohl W, Roller-Wirnsberger R, Spranger O, Valenta R, Akdis M, Akdis

Abstract:

Link para artigo

Severe asthma at COVID-19 time: what's new on biologic therapies

Patrucco F, Villa E, Foci V, Benfante A, Bellocchia M, Solidoro P.

Abstract:

Link para artigo

nCOV-19 peptides mass fingerprinting identification, binding, and blocking of inhibitors flavonoids and anthraquinone of Moringa oleifera and hydroxychloroquine

Hamza M, Ali A, Khan S, Ahmed S, Attique Z, Ur Rehman S, Khan A, Ali H, Rizwan M, Munir A, Khan AM, Siddique F, Mehmood A, Nouroz F, Khan S.

Abstract:

Link para artigo

Phototherapy and vitamin D: the importance in COVID-19 era

Megna M, Fabbrocini G, Villani A.

Abstract:

Link para artigo

A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance

Ahn BY, Kang CK, Seo JD, Choe PG, Song SH, Park WB, Park SW, Kim NJ, Oh MD.

Abstract:

Link para artigo

Advantages of Using Lotteries to Select Participants for High-Demand Covid-19 Treatment Trials

Iyer AA, Hendriks S, Rid A.

Abstract:

Link para artigo

Effectiveness and safety of glucocorticoids to treat COVID-19: a rapid review and meta-analysis

Lu S, Zhou Q, Huang L, Shi Q, Zhao S, Wang Z, Li W, Tang Y, Ma Y, Luo X, Fukuoka T, Ahn HS, Lee MS, Luo Z, Liu E, Chen Y, Zhou C, Peng D.

Abstract:

Link para artigo

Effectiveness of intravenous immunoglobulin for children with severe COVID-19: a rapid review

Zhang J, Yang Y, Yang N, Ma Y, Zhou Q, Li W, Wang X, Huang L, Luo X, Fukuoka T, Ahn HS, Lee MS, Luo Z, Chen Y, Liu E, Yang K, Fu Z.

Abstract:

Link para artigo

Potential effectiveness and safety of antiviral agents in children with coronavirus disease 2019: a rapid review and meta-analysis

Shi Q, Zhou Q, Wang X, Liao J, Yu Y, Wang Z, Lu S, Ma Y, Xun Y, Luo X, Li W, Fukuoka T, Ahn HS, Lee MS, Luo Z, Liu E, Chen Y, Li Q, Yang K, Guan Q; COVID-19 Evidence and Recommendations Working Group.

Abstract:

Link para artigo

Supportive care for patient with respiratory diseases: an umbrella review

Luo X, Lv M, Wang X, Long X, Ren M, Zhang X, Liu Y, Li W, Zhou Q, Ma Y, Fukuoka T, Ahn HS, Lee MS, Luo Z, Liu E, Wang X, Chen Y; COVID-19 Evidence and Recommendations Working Group.

Abstract:

Link para artigo

Efficacy and safety of antibiotic agents in children with COVID-19: a rapid review

Wang J, Tang Y, Ma Y, Zhou Q, Li W, Baskota M, Yang Y, Wang X, Li Q, Luo X, Fukuoka T, Ahn HS, Lee MS, Luo Z, Liu E, Chen Y; COVID-19 Evidence and Recommendations Working Group.

Abstract:

Link para artigo

Doxycycline as a potential partner of COVID-19 therapies

Malek AE, Granwehr BP, Kontoyiannis DP.

Abstract:

Link para artigo

Effect of combination antiviral therapy on hematological profiles in 151 adults hospitalized with severe coronavirus disease 2019

Li X, Yang Y, Liu L, Yang X, Zhao X, Li Y, Ge Y, Shi Y, Lv P, Zhang J, Bai T, Zhou H, Luo P, Huang S.

Abstract:

Link para artigo

Chloroquine cardiac effects and toxicity.A short update

Mubagwa K.

Abstract:

Link para artigo

Emerging trends in COVID-19 treatment: learning from inflammatory conditions associated with cellular therapies

Cancio M, Ciccocioppo R, Rocco PRM, Levine BL, Bronte V, Bollard CM, Weiss D, Boelens JJ, Hanley PJ.

Abstract:

Link para artigo

Can we use noninvasive respiratory therapies in COVID-19 pandemic?

Díaz Lobato S, Carratalá Perales JM, Alonso Íñigo JM.

Abstract:

Link para artigo

The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al

Piantoni S, Colombo E, Airò P, Tincani A, Brucato A, Franceschini F, Andreoli L, Furloni R, Scarsi M.

Abstract:

Link para artigo

Comment on "Colchicine may not be effective in COVID-19 infection; it may even be harmful?"

Kobak S.

Abstract:

Link para artigo

Az első két sikeres, convalescens friss fagyasztott plazmával történő terápia hazai alkalmazása intenzív osztályon kezelt, kritikus állapotú, COVID-19-fertőzésben szenvedő betegekben

Bobek I, Gopcsa L, Réti M, Bekő G, Hancz L, Lakatos B, Molnár E, Nagy S, Reményi P, Sebestyén G, Sinkó J, Szlávik J, Szolnoky M, Vályi-Nagy I.

Abstract:

Link para artigo

Can hyperimmune anti-CMV globulin substitute for convalescent plasma for treatment of COVID-19?

Basic-Jukic N.

Abstract:

Link para artigo

A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir

Liang C, Tian L, Liu Y, Hui N, Qiao G, Li H, Shi Z, Tang Y, Zhang D, Xie X, Zhao X.

Abstract:

Link para artigo

Repurposing old drugs as antiviral agents for coronaviruses

Yang CW, Peng TT, Hsu HY, Lee YZ, Wu SH, Lin WH, Ke YY, Hsu TA, Yeh TK, Huang WZ, Lin JH, Sytwu HK, Chen CT, Lee SJ.

Abstract:

Link para artigo

Investigational Therapies for the Treatment of COVID-19: Updates from Ongoing Clinical Trials

Abrams-Downey A, Saabiye J, Vidaurrazaga M.

Abstract:

Link para artigo

Telephonic monitoring of patients on clozapine in the resource-poor setting during the COVID-19 pandemic

Grover S, Mishra E, Chakrabarti S, Mehra A, Sahoo S.

Abstract:

Link para artigo

Successful Treatment of Severe COVID-19 Pneumonia With Clazakizumab in a Heart Transplant Recipient: A Case Report

Vaidya G, Czer LSC, Kobashigawa J, Kittleson M, Patel J, Chang D, Kransdorf E, Shikhare A, Tran H, Vo A, Ammerman N, Huang E, Zabner R, Jordan S.

Abstract:

Link para artigo

Global governance for COVID-19 vaccines

The Lancet.

Abstract:

Link para artigo

A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application

Contini C, Enrica Gallenga C, Neri G, Maritati M, Conti P.

Abstract:

Link para artigo

Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes

Taghavi-Farahabadi M, Mahmoudi M, Soudi S, Hashemi SM.

Abstract:

Link para artigo

COVID-19 and pneumonia: a role for the uPA/uPAR system

D'Alonzo D, De Fenza M, Pavone V.

Abstract:

Link para artigo

Statins and other drugs: Facing COVID-19 as a vascular disease

Sanchis-Gomar F, Perez-Quilis C, Favaloro EJ, Lippi G.

Abstract:

Link para artigo

SGLT2 inhibition during the COVID-19 epidemic: friend or foe?

Scheen AJ.

Abstract:

Link para artigo

Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients

Bonam SR, Kaveri SV, Sakuntabhai A, Gilardin L, Bayry J.

Abstract:

Link para artigo

Systematic review of registered trials of Hydroxychloroquine prophylaxis for COVID-19 health-care workers at the first third of 2020

Bienvenu AL, Marty AM, Jones MK, Picot S.

Abstract:

Link para artigo

Novel Approach for Low-Dose Pulmonary Delivery of Hydroxychloroquine in COVID-19

Fassihi SC, Nabar NR, Fassihi R.

Abstract:

Link para artigo

Statins: Could an old friend help the fight against COVID-19?

Rodrigues-Diez RR, Tejera-Muñoz A, Marquez-Exposito L, Rayego-Mateos S, Sanchez LS, Marchant V, Santamaria LT, Ramos AM, Ortiz A, Egido J, Ruiz-Ortega M.

Abstract:

Link para artigo

The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study

Vahedi E, Ghanei M, Ghazvini A, Azadi H, Izadi M, Panahi Y, Fathi S, Salesi M, Saadat SH, Ghazale AH, Rezapour M, Mozafari A, Zand N, Parsaei MR, Ranjkesh MH, Jafari R, Movaseghi F, Darabi E.

Abstract:

Link para artigo

A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab

Cai S, Sun W, Li M, Dong L.

Abstract:

Link para artigo

Could an Unrelated Live Attenuated Vaccine Serve as a Preventive Measure To Dampen Septic Inflammation Associated with COVID-19 Infection?

Fidel PL Jr, Noverr MC.

Abstract:

Link para artigo

Covid-19: Public health agencies review whether vitamin D supplements could reduce risk

Torjesen I.

Abstract:

Link para artigo

Pharmacovigilance in patients with diabetes: A data-driven analysis identifying specific RAS antagonists with adverse pulmonary safety profiles that have implications for COVID-19 morbidity and mortality

Stafford EG, Riviere JE, Xu X, Kawakami J, Wyckoff GJ, Jaberi-Douraki M.

Abstract:

Link para artigo

Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof)

Vijayvargiya P, Esquer Garrigos Z, Castillo Almeida NE, Gurram PR, Stevens RW, Razonable RR.

Abstract:

Link para artigo

Current treatment approaches for COVID-19 and the clinical value of transfusion-related technologies

Li Y, Liu S, Zhang S, Ju Q, Zhang S, Yang Y, Wang H.

Abstract:

Link para artigo

Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial

Desilles JP, Gregoire C, Le Cossec C, Lambert J, Mophawe O, Losser MR, Lambiotte F, Le Tacon S, Cantier M, Engrand N, Trouiller P, Pottecher J.

Abstract:

Link para artigo

Letter to the editor: efficacy of different methods of combination regimen administrations including dexamethasone, intravenous immunoglobulin, and interferon-beta to treat critically ill COVID-19 patients: a structured summary of a study protocol for a randomized controlled trial

Abdolahi N, Kaheh E, Golsha R, Khodabakhshi B, Norouzi A, Khandashpoor M, Besharat S, Tavassoli S, Livani S, Azimi SA, Gharib MH, Peivandi B, Fazel A, Shirzad-Aski H, Roshandel G.

Abstract:

Link para artigo

AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trial

Griffiths G, Fitzgerald R, Jaki T, Corkhill A, Marwood E, Reynolds H, Stanton L, Ewings S, Condie S, Wrixon E, Norton A, Radford M, Yeats S, Robertson J, Darby-Dowman R, Walker L, Khoo S; UK NIHR community.

Abstract:

Link para artigo

Non-optimal effectiveness of convalescent plasma transfusion and hydroxychloroquine in treating COVID-19: a case report

Xu TM, Lin B, Chen C, Liu LG, Xue Y.

Abstract:

Link para artigo

"Monoclonal-Type" Plastic Antibodies for COVID-19 Treatment: What Is the Idea?

Puoci F.

Abstract:

Link para artigo

Vaccines against Coronaviruses: The State of the Art

Conte C, Sogni F, Affanni P, Veronesi L, Argentiero A, Esposito S.

Abstract:

Link para artigo

Vaccines and Therapies in Development for SARS-CoV-2 Infections

Wu D, Koganti R, Lambe UP, Yadavalli T, Nandi SS, Shukla D.

Abstract:

Link para artigo

Model informed dosing of Hydroxycholoroquine in COVID-19 patients: Learnings from the recent experience, remaining uncertainties and Gaps

Thémans P, Dauby N, Schrooyen L, Lebout F, Delforge M, Nasreddine R, Libois A, Payen MC, Konopnicki D, Wuillaume F, Lescrainier C, Verlinden V, Dogné JM, Hamdani J, Musuamba FT.

Abstract:

Link para artigo

Assessing the risk of seizures with chloroquine or hydroxychloroquine therapy for COVID-19 in persons with epilepsy

Pati S, Houston T.

Abstract:

Link para artigo

Hydroxychloroquine use in COVID-19: what is the basis for baseline tests?

Afra TP, T MR, Bishnoi A, Hafi NB.

Abstract:

Link para artigo

Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection

Clementi N, Ferrarese R, Criscuolo E, Diotti RA, Castelli M, Scagnolari C, Burioni R, Antonelli G, Clementi M, Mancini N.

Abstract:

Link para artigo

Rationale for Evaluating PDE4 Inhibition for Mitigating against Severe Inflammation in COVID-19 Pneumonia and Beyond

Bridgewood C, Damiani G, Sharif K, Watad A, Bragazzi NL, Quartuccio L, Savic S, McGonagle D.

Abstract:

Link para artigo

Timing of antiviral treatment initiation is critical to reduce SARS-CoV-2 viral load

Gonçalves A, Bertrand J, Ke R, Comets E, de Lamballerie X, Malvy D, Pizzorno A, Terrier O, Rosa Calatrava M, Mentré F, Smith P, Perelson AS, Guedj J.

Abstract:

Link para artigo

Clearance of chloroquine and hydroxychloroquine by the Seraph® 100 Microbind® Affinity blood filter - approved for the treatment of COVID-19 patients

Seffer MT, Martens-Lobenhoffer J, Schmidt JJ, Eden G, Bode-Böger SM, Kielstein JT.

Abstract:

Link para artigo

Vaccine development and therapeutic design for 2019-nCoV/SARS-CoV-2: Challenges and chances

Ghaebi M, Osali A, Valizadeh H, Roshangar L, Ahmadi M.

Abstract:

Link para artigo

Persisting SARS-CoV-2 viremia after rituximab therapy: Two cases with fatal outcome and a review of literature

Tepasse PR, Hafezi W, Lutz M, Kühn J, Wilms C, Wiewrodt R, Sackarnd J, Keller M, Schmidt HH, Vollenberg R.

Abstract:

Link para artigo

Harnessing resolving-based therapeutics to treat pulmonary viral infections: What can the future offer to COVID-19?

Sousa LP, Pinho V, Teixeira MM.

Abstract:

Link para artigo

A Comprehensive Review on Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome

Khiali S, Khani E, Entezari-Maleki T.

Abstract:

Link para artigo

Effect of angiotensin II blockers on the prognosis of COVID-19: a toxicological view

Shirazi FM, Banerji S, Nakhaee S, Mehrpour O.

Abstract:

Link para artigo

Possible role of vitamin D in Covid-19 infection in pediatric population

Panfili FM, Roversi M, D'Argenio P, Rossi P, Cappa M, Fintini D.

Abstract:

Link para artigo

Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and Risks

Crisafulli S, Isgrò V, La Corte L, Atzeni F, Trifirò G.

Abstract:

Link para artigo

Colchicine as a possible therapeutic option in COVID-19 infection

Parra-Medina R, Sarmiento-Monroy JC, Rojas-Villarraga A, Garavito E, Montealegre-Gómez G, Gómez-López A.

Abstract:

Link para artigo

Antithrombotic Therapies in COVID-19 Disease: a Systematic Review

Maldonado E, Tao D, Mackey K.

Abstract:

Link para artigo

Regulating drugs, medical devices, and diagnostic tests in the European Union: early lessons from the COVID-19 pandemic?

Fraser AG, Szymański P, Macintyre E, Landray M.

Abstract:

Link para artigo

Pain Management During COVID-19 and Steroids: Striking a Balance

Cohen SP, Hooten WM, Phillips CR.

Abstract:

Link para artigo

Real-life experience of tocilizumab use in COVID-19 patients

Madenidou AV, Bukhari M.

Abstract:

Link para artigo

Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect

Stader F, Khoo S, Stoeckle M, Back D, Hirsch HH, Battegay M, Marzolini C.

Abstract:

Link para artigo

Compassionate use of hydroxychloroquine in clinical practice for patients with mild to severe Covid-19 in a French university hospital

Paccoud O, Tubach F, Baptiste A, Bleibtreu A, Hajage D, Monsel G, Tebano G, Boutolleau D, Klement E, Godefroy N, Palich R, Itani O, Fayssal A, Valantin MA, Tubiana R, Burrel S, Calvez V, Caumes E, Marcelin AG, Pourcher V.

Abstract:

Link para artigo

COVID-19: therapeutic approaches description and discussion

Trindade GG, Caxito SMC, Xavier AREO, Xavier MAS, BrandÃo F.

Abstract:

Link para artigo

Can mesenchymal stem cell therapy be the interim management of COVID-19?

Bamba C, Singh SP, Choudhury S.

Abstract:

Link para artigo

Current global vaccine and drug efforts against COVID-19: Pros and cons of bypassing animal trials

Deb B, Shah H, Goel S.

Abstract:

Link para artigo

Low dose lung radiation therapy for pneumonia: an examination of historical dose distributions

Kirkby C, Mackenzie M.

Abstract:

Link para artigo

Treatment strategies of hospitalized patients with coronavirus disease-19

Huang Y, Cai C, Zang J, Xie J, Xu D, Zheng F, Zhan T, Huang K, Wang Y, Wang X, Hu ZY, Deng Y, Xie Y.

Abstract:

Link para artigo

Pernicious anaemia: switch to oral B12 supplementation to reduce risk of covid-19 transmission

Takhar A.

Abstract:

Link para artigo

Administration of end-of-life drugs by family caregivers during covid-19: opportunity for future home prescribing plans

Julião M.

Abstract:

Link para artigo

Potential role of memantine in the prevention and treatment of COVID-19: its antagonism of nicotinic acetylcholine receptors (nAChR) and beyond

Hasanagic S, Serdarevic F.

Abstract:

Link para artigo

Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data

Abstract:

Link para artigo

The COVID-19 pandemic: is there a role for magnesium? Hypotheses and perspectives

Iotti S, Wolf F, Mazur A, Maier JA.

Abstract:

Link para artigo

Noradrenergic and serotonergic drugs may have opposing effects on COVID-19 cytokine storm and associated psychological effects

Fitzgerald PJ.

Abstract:

Link para artigo

Potential COVID-19 infection in patients with severe multiple sclerosis treated with alemtuzumab

Matías-Guiu J, Montero-Escribano P, Pytel V, Porta-Etessam J, Matias-Guiu JA.

Abstract:

Link para artigo

Protection against COVID-19 injury by qingfei paidu decoction via anti-viral, anti-inflammatory activity and metabolic programming

Chen J, Wang YK, Gao Y, Hu LS, Yang JW, Wang JR, Sun WJ, Liang ZQ, Cao YM, Cao YB.

Abstract:

Link para artigo

Aminoglycosides can be a better choice over macrolides in COVID-19 regimen: Plausible mechanism for repurposing strategy

Chalichem NSS, Bethapudi B, Mundkinajeddu D.

Abstract:

Link para artigo

Potential inhibitors of the interaction between ACE2 and SARS-CoV-2 (RBD), to develop a drug

Benítez-Cardoza CG, Vique-Sánchez JL.

Abstract:

Link para artigo

Impact of medication discontinuation on patients with inflammatory bowel disease during the COVID-19 outbreak

Chen J, Peng X, Zhang M, Zhi M.

Abstract:

Link para artigo

Aminosalicylates and COVID-19: Facts or Coincidences?

Magro F, Dias CC, Morato M.

Abstract:

Link para artigo

COVID-19, SEVERE ASTHMA AND BIOLOGICS

García-Moguel I, Campos RD, Charterina SA, Rodríguez CF, Crespo JF.

Abstract:

Link para artigo

COVID-19 and hydroxychloroquine: Is the wonder drug failing?

Paliani U, Cardona A.

Abstract:

Link para artigo

Tocilizumab treatment for Cytokine Release Syndrome in hospitalized COVID-19 patients: survival and clinical outcomes

Price CC, Altice FL, Shyr Y, Koff A, Pischel L, Goshua G, Azar MM, Mcmanus D, Chen SC, Gleeson SE, Britto CJ, Azmy V, Kaman K, Gaston DC, Davis M, Burrello T, Harris Z, Villanueva MS, Aoun-Barakat L, Kang I, Seropian S, Chupp G, Bucala R, Kaminski N, Lee AI, LoRusso PM, Topal JE, Dela Cruz C, Malinis M.

Abstract:

Link para artigo

Drugs acting on renin angiotensin system and use in ill patients with COVID-19

Alexandre J, Cracowski JL, Richard V, Bouhanick B; French Society of Pharmacology and Therapeutics (SFPT).

Abstract:

Link para artigo

Ultrafast response of the French Society of Pharmacology and Therapeutics to the COVID-19 pandemic

Cracowski JL, Molimard M, Richard V.

Abstract:

Link para artigo

Are Genetic Vaccines the Right Weapon against COVID-19?

Conforti A, Marra E, Roscilli G, Palombo F, Ciliberto G, Aurisicchio L.

Abstract:

Link para artigo

Chloroquine-Induced First-Episode Psychosis in a Patient Self-medicated for COVID-19

Ambar Akkaoui M, Lejoyeux M, Geoffroy PA.

Abstract:

Link para artigo

Appropriate selection of convalescent plasma donors for COVID-19

Tedder RS, Semple MG.

Abstract:

Link para artigo

First do no harm-beware the risk of therapeutic plasma exchange in severe COVID-19

Stahl K, Bode C, David S.

Abstract:

Link para artigo

Facts and myths: Efficacies of repurposing chloroquine and hydroxychloroquine for the treatment of COVID-19

Al-Bari MAA.

Abstract:

Link para artigo

Repurposing minocycline for COVID-19 management: mechanisms, opportunities and challenges

Singh H, Kakkar AK, Chauhan P.

Abstract:

Link para artigo

Update Alert: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians

Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, Miller MC, Abraham GM, Obley AJ, Forciea MA, Jokela JA, Humphrey LL.

Abstract:

Link para artigo

Involvement of Cisgender and Transgender Individuals in Studies on the Impact of Hormonal Therapy on COVID-19

Wozniak RJ, Nixon DF, Marston JL.

Abstract:

Link para artigo

Discovery of New Hydroxyethylamine Analogs against 3CL(pro) Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure-Activity Relationship Studies

Kumar S, Sharma PP, Shankar U, Kumar D, Joshi SK, Pena L, Durvasula R, Kumar A, Kempaiah P, Poonam, Rathi B.

Abstract:

Link para artigo

Dexamethasone for COVID-19? Not so fast

Theoharides TC, Conti P.

Abstract:

Link para artigo

Possible Old Drugs for Repositioning in COVID-19 Treatment: Combating Cytokine Storms from Haloperidol to Anti-interleukin Agents

Tulgar S, Ahıskalıoğlu A, Kök A, Thomas DT.

Abstract:

Link para artigo

Can We Reduce Mortality of COVID-19 if We do Better in Glucose Control?

Deng M, Jiang L, Ren Y, Liao J.

Abstract:

Link para artigo

Network Medicine Framework for Identifying Drug Repurposing Opportunities for COVID-19

Gysi DM, Do Valle Í, Zitnik M, Ameli A, Gan X, Varol O, Sanchez H, Baron RM, Ghiassian D, Loscalzo J, Barabási AL.

Abstract:

Link para artigo

Prediction of repurposed drugs for treating lung injury in COVID-19

He B, Garmire L.

Abstract:

Link para artigo

Azithromycin Should Not Be Used to Treat COVID-19

Lighter J, Raabe V.

Abstract:

Link para artigo

Heated Air Delivery by Micro-Sauna: An Experimental Treatment Prototype Concept for Coronavirus Disease 2019

Knio ZO, Shelton JA, O'Gara T.

Abstract:

Link para artigo

The use of exhaled nitric oxide and peak expiratory flow to demonstrate improved breathability and antimicrobial properties of novel face mask made with sustainable filter paper and Folium Plectranthii amboinicii oil: additional option for mask shortage during COVID-19 pandemic

Duong-Quy S, Ngo-Minh X, Tang-Le-Quynh T, Tang-Thi-Thao T, Nguyen-Quoc B, Le-Quang K, Tran-Thanh D, Doan-Thi-Quynh N, Canty E, Do T, Craig T.

Abstract:

Link para artigo

A Pharmacovigilance Study of Hydroxychloroquine Cardiac Safety Profile: Potential Implication in COVID-19 Mitigation

Singh AP, Tousif S, Umbarkar P, Lal H.

Abstract:

Link para artigo

Impact of anti-rheumatic drugs and steroids on clinical course and prognosis of COVID-19

Gazzaruso C, Carlo Stella N, Mariani G, Tamburlini A, Garini P, Freddi E, Ravetto C, Coppola A, Gallotti P.

Abstract:

Link para artigo

Calling for an exponential escalation scheme in vaccine development for COVID-19

Wehling M.

Abstract:

Link para artigo

Radionuclide therapy in the time of COVID-19

Brabander T, Hofland H.

Abstract:

Link para artigo

Corticosteroids in patients with COVID-19: what about the control group?

Chroboczek T, Lacoste M, Wackenheim C, Challan-Belval T, Amar B, Boisson T, Hubac J, Leduc D, Masse C, Dechaene V, Touhiri-Maximin L, Megessier S, Lassale C.

Abstract:

Link para artigo

Off-label therapy targeting pathogenic inflammation in COVID-19

Romani L, Tomino C, Puccetti P, Garaci E.

Abstract:

Link para artigo

A Role for Metal-Based Drugs in Fighting COVID-19 Infection? The Case of Auranofin

Marzo T, Messori L.

Abstract:

Link para artigo

The journey of remdesivir: from Ebola to COVID-19

Pardo J, Shukla AM, Chamarthi G, Gupte A.

Abstract:

Link para artigo

Anwendung von Biologika bei allergischen und Typ-2-entz√ºndlichen Erkrankungen in der aktuellen Covid-19-Pandemie(a, b, c): Positionspapier des √Ñrzteverbands Deutscher Allergologen (AeDA)A, der Deutschen Gesellschaft f√ºr Allergologie und klinische Immunologie (DGAKI)B, der Gesellschaft f√ºr P√

Klimek L, Pfaar O, Worm M, Eiwegger T, Hagemann J, Ollert M, Untersmayr E, Hoffmann-Sommergruber K, Vultaggio A, Agache I, Bavbek S, Bossios A, Casper I, Chan S, Chatzipetrou A, Vogelberg C, Firinu D, Kauppi P, Kolios A, Kothari A, Matucci A, Palomares O, Szépfalusi Z, Pohl W, Hötzenecker W, Rosenkranz A, Bergmann KC, Bieber T, Buhl R, Buters J, Darsow U, Keil T, Kleine-Tebbe J, Lau S, Maurer M, Merk H, Mösges R, Saloga J, Staubach P, Jappe U, Rabe C, Rabe U, Vogelmeier C, Biedermann T, Jung

Abstract:

Link para artigo

Immune status could determine efficacy of COVID-19 therapies

Cully M.

Abstract:

Link para artigo

The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development

Dutta NK, Mazumdar K, Gordy JT.

Abstract:

Link para artigo

COVID-19 in patients with rheumatological diseases treated with anti-TNF

Brito CA, Paiva JG, Pimentel FN, Guimar√£es RS, Moreira MR.

Abstract:

Link para artigo

Response to: 'COVID-19 in patients with rheumatological diseases treated with Anti-TNF' by Brito et al and 'Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China 'hot pot' versus in US 'hot pot': similarity and difference' by Zhao et al

D'Silva KM, Serling-Boyd N, Wallwork R, Hsu T, Sparks JA, Wallace ZS.

Abstract:

Link para artigo

Covid-19: Low dose steroid cuts death in ventilated patients by one third, trial finds

Mahase E.

Abstract:

Link para artigo

Could Respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, Prove to be Beneficial as an Adjunct Treatment in COVID-19?

Karampela I, Dalamaga M.

Abstract:

Link para artigo

Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial

Eckhardt CM, Cummings MJ, Rajagopalan KN, Borden S, Bitan ZC, Wolf A, Kantor A, Briese T, Meyer BJ, Jacobson SD, Scotto D, Mishra N, Philip NM, Stotler BA, Schwartz J, Shaz B, Spitalnik SL, Eisenberger A, Hod EA, Justman J, Cheung K, Lipkin WI, O'Donnell MR.

Abstract:

Link para artigo

Erythropoietin as candidate for supportive treatment of severe COVID-19

Ehrenreich H, Weissenborn K, Begemann M, Busch M, Vieta E, Miskowiak KW.

Abstract:

Link para artigo

Case report: use of lenzilumab and tocilizumab for the treatment of coronavirus disease 2019

Melody M, Nelson J, Hastings J, Propst J, Smerina M, Mendez J, Guru P.

Abstract:

Link para artigo

The broad-spectrum antiviral recommendations for drug discovery against COVID-19

Hazafa A, Ur-Rahman K, Haq IU, Jahan N, Mumtaz M, Farman M, Naeem H, Abbas F, Naeem M, Sadiqa S, Bano S.

Abstract:

Link para artigo

Potential Antiviral Options against SARS-CoV-2 Infection

Ianevski A, Yao R, Fenstad MH, Biza S, Zusinaite E, Reisberg T, Lysvand H, Løseth K, Landsem VM, Malmring JF, Oksenych V, Erlandsen SE, Aas PA, Hagen L, Pettersen CH, Tenson T, Afset JE, Nordbø SA, Bjørås M, Kainov DE.

Abstract:

Link para artigo

Reaction Cycles of Halogen Species in the Immune Defense: Implications for Human Health and Diseases and the Pathology and Treatment of COVID-19

Lu QB.

Abstract:

Link para artigo

Nrf2 Activator PB125(®) as a Potential Therapeutic Agent against COVID-19

McCord JM, Hybertson BM, Cota-Gomez A, Geraci KP, Gao B.

Abstract:

Link para artigo

Potential of Flavonoid-Inspired Phytomedicines against COVID-19

Ngwa W, Kumar R, Thompson D, Lyerly W, Moore R, Reid TE, Lowe H, Toyang N.

Abstract:

Link para artigo

Antimicrobial Photodynamic Therapy in the Control of COVID-19

Almeida A, Faustino MAF, Neves MGPMS.

Abstract:

Link para artigo

Strategies to Prevent SARS-CoV-2-Mediated Eosinophilic Disease in Association with COVID-19 Vaccination and Infection

Simon HU, Karaulov AV, Bachmann MF.

Abstract:

Link para artigo

Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial

Dastan F, Nadji SA, Saffaei A, Marjani M, Moniri A, Jamaati H, Hashemian SM, Baghaei P, Abedini A, Varahram M, Yousefian S, Tabarsi P.

Abstract:

Link para artigo

COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature

Di Lorenzo G, Di Trolio R, Kozlakidis Z, Busto G, Ingenito C, Buonerba L, Ferrara C, Libroia A, Ragone G, Ioio CD, Savastano B, Polverino M, De Falco F, Iaccarino S, Leo E.

Abstract:

Link para artigo

Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019

Di Cosimo S, Malfettone A, Pérez-García JM, Llombart-Cussac A, Miceli R, Curigliano G, Cortés J.

Abstract:

Link para artigo

Current emerging SARS-CoV-2 pandemic: Potential direct/indirect negative impacts of virus persistence and related therapeutic drugs on the aquatic compartments

Race M, Ferraro A, Galdiero E, Guida M, Núñez-Delgado A, Pirozzi F, Siciliano A, Fabbricino M.

Abstract:

Link para artigo

Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b

Hong SI, Ryu BH, Chong YP, Lee S, Kim S, Kim HC, Hong KW, Bae IG, Cho OH.

Abstract:

Link para artigo

COVID-19 in a patient with severe asthma treated with Omalizumab

Lommatzsch M, Stoll P, Christian Virchow J.

Abstract:

Link para artigo

Repositioning of 8565 Existing Drugs for COVID-19

Gao K, Nguyen DD, Chen J, Wang R, Wei G.

Abstract:

Link para artigo

The comparison of the effectiveness of lincocin® and azitro® in the treatment of covid-19-associated pneumonia: A prospective study

Guvenmez O, Keskin H, Ay B, Birinci S, Kanca MF.

Abstract:

Link para artigo

Fibrinolysis and COVID-19: a plasmin paradox

Medcalf RL, Keragala CB, Myles PS.

Abstract:

Link para artigo

Acute generalized exanthematous pustulosis induced by empiric hydroxychloroquine for presumed COVID-19

Enos T, Jeong HS, Vandergriff T, Jacobe HT, Chong BF.

Abstract:

Link para artigo

Clinical use of Convalescent Plasma in the COVID-19 pandemic; a transfusion-focussed gap analysis with recommendations for future research priorities

Al-Riyami AZ, Schäfer R, van der Berg K, Bloch EM, Escourt LJ, Goel R, Hindawi S, Josephson CD, Land K, McQuilten ZK, Spitalnik SL, Wood EM, Devine DV, So-Osman C; ISBT Convalescent Plasma Working Group.

Abstract:

Link para artigo

Baricitinib: A review of pharmacology, safety and emerging clinical experience in COVID-19

Cj Jorgensen S, Ly Tse C, Burry L, Dresser LD.

Abstract:

Link para artigo

Association Between US Administration Endorsement of Hydroxychloroquine for COVID-19 and Outpatient Prescribing

Harrigan JJ, Hubbard RA, Thomas S, Riello RJ 3rd, Bange E, Mamtani M, Mamtani R.

Abstract:

Link para artigo

Decoy ACE2-expressing extracellular vesicles that competitively bind SARS-CoV-2 as a possible COVID-19 therapy

Inal JM.

Abstract:

Link para artigo

Fibrinolytic therapy for refractory COVID-19 acute respiratory distress syndrome: Scientific rationale and review

Barrett CD, Moore HB, Moore EE, McIntyre RC, Moore PK, Burke J, Hua F, Apgar J, Talmor DS, Sauaia A, Liptzin DR, Veress LA, Yaffe MB.

Abstract:

Link para artigo

Using heparin molecules to manage COVID-2019

Liu J, Li J, Arnold K, Pawlinski R, Key NS.

Abstract:

Link para artigo

Emergence of institutional antithrombotic protocols for coronavirus 2019

Cohoon KP, Mahé G, Tafur AJ, Spyropoulos AC.

Abstract:

Link para artigo

The contact activation system as a potential therapeutic target in patients with COVID-19

Shatzel JJ, DeLoughery EP, Lorentz CU, Tucker EI, Aslan JE, Hinds MT, Gailani D, Weitz JI, McCarty OJT, Gruber A.

Abstract:

Link para artigo

Management of clozapine treatment during the COVID-19 pandemic

Gee S, Gaughran F, MacCabe J, Shergill S, Whiskey E, Taylor D.

Abstract:

Link para artigo

Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease

Ma C, Sacco MD, Hurst B, Townsend JA, Hu Y, Szeto T, Zhang X, Tarbet B, Marty MT, Chen Y, Wang J.

Abstract:

Link para artigo

Efficacy and safety of Jinhua Qinggan granules for coronavirus disease 2019 (COVID-19): A protocol of a systematic review and meta-analysis

Chen H, Song YP, Gao K, Zhao LT, Ma L.

Abstract:

Link para artigo

The efficacy and safety of Jinhua Qinggan granule (JHQG) in the treatment of coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta analysis

Zhang Q, Cao F, Wang Y, Xu X, Sun Y, Li J, Qi X, Sun S, Ji G, Song B.

Abstract:

Link para artigo

Withdrawing mycophenolate mofetil in treating a young kidney transplant recipient with COVID-19: A case report

Chen D, Yang B, Zhang Y, Chen L, Wei L, Zhang W, Wang X, Tong X, Chen Z.

Abstract:

Link para artigo

Intermittent high dosage oxygen treats COVID-19 infection: the Chinese studies

James PB.

Abstract:

Link para artigo

Hyperbaric oxygen treatment of novel coronavirus (COVID-19) respiratory failure

Harch PG.

Abstract:

Link para artigo

[Anti-cytokine therapy in novel coronavirus disease (COVID-19) – the first administration of tocilizumab in Hungary at a department of infectology]

Lakatos B, Gopcsa L, Gondos E, Riczu A, Várnai Z, Nagy É, Molnár E, Bekő G, Bobek I, Reményi P, Szlávik J, Sinkó J, Vályi-Nagy I.

Abstract:

Link para artigo

Hydroxychloroquine for covid-19: the end of the line?

Mahase E.

Abstract:

Link para artigo

Repositioning of pentoxifylline as an immunomodulator and regulator of the renin-angiotensin system in the treatment of COVID-19

Maldonado V, Loza-Mejía MA, Chávez-Alderete J.

Abstract:

Link para artigo

A review of potential treatments to date in COVID-19 patients according to the stage of the disease

Alsuliman T, Alasadi L, Alkharat B, Srour M, Alrstom A.

Abstract:

Link para artigo

COVID-19 vaccine development: Time to consider SARS-CoV-2 challenge studies?

Schaefer GO, Tam CC, Savulescu J, Voo TC.

Abstract:

Link para artigo

Inhaled nitric oxide treatment in spontaneously breathing COVID-19 patients

Parikh R, Wilson C, Weinberg J, Gavin D, Murphy J, Reardon CC.

Abstract:

Link para artigo

In COVID-19, adding lopinavir-ritonavir to usual care did not shorten time to clinical improvement

Yang P, Tekwani S, Martin GS.

Abstract:

Link para artigo

Correction: Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19

Abstract:

Link para artigo

Monoclonal Antibodies for Prevention and Treatment of COVID-19

Marovich M, Mascola JR, Cohen MS.

Abstract:

Link para artigo

Convalescent plasma and covid-19 treatment

Joob B, Wiwanitkit V.

Abstract:

Link para artigo

Reply to: What we are talking about when we talk of steroid in COVID-19?

Piraccini E, Byrne H, Caruso G, Piaccione L, Taddei S.

Abstract:

Link para artigo

Repurposing cefuroxime for treatment of COVID-19: a scoping review of in silico studies

Durojaiye AB, Clarke JD, Stamatiades GA, Wang C.

Abstract:

Link para artigo

Possible therapeutic agents for COVID-19: a comprehensive review

Elhusseiny KM, Abd-Elshahed Abd-Elhay F, Kamel MG.

Abstract:

Link para artigo

[Clinical observation of heat-sensitive moxibustion treatment for coronavirus disease 2019]

Huang XB, Xie DY, Qiu Q, Shen Y, Jiao L, Li QL, Chen RX.

Abstract:

Link para artigo

[Analysis on the theory and clinical ideas of acupuncture and moxibustion for the prevention and treatment of coronavirus disease 2019]

Liu B, Wang H, Zhou ZY, Chang XR, Zhang W, Liu BY.

Abstract:

Link para artigo

Uncertainty about the Efficacy of Remdesivir on COVID-19

Yoo JH.

Abstract:

Link para artigo

Inhibition of metalloproteinases in therapy for severe lung injury due to COVID-19

Solun B, Shoenfeld Y.

Abstract:

Link para artigo

The critical role of futility analysis in the pursuit of effective treatments for COVID-19

Su Z.

Abstract:

Link para artigo

Commentary on "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial" by Gautret et al

Toumi M, Aballea S.

Abstract:

Link para artigo

Hochdosiertes Chloroquin bei COVID-19 gefährlich

Abstract:

Link para artigo

[Comment] Treatment strategies to fight the new coronavirus SARS-CoV-2: A challenge for a Rubik's Cube solver

Tsitoura E, Bibaki E, Bolaki M, Vasarmidi E, Trachalaki A, K Symvoulakis E, A Spandidos D, M Antoniou K.

Abstract:

Link para artigo

Mechanism of Dayuanyin in the treatment of coronavirus disease 2019 based on network pharmacology and molecular docking

Ruan X, Du P, Zhao K, Huang J, Xia H, Dai D, Huang S, Cui X, Liu L, Zhang J.

Abstract:

Link para artigo

Antiviral Therapy during the Coronavirus Disease (COVID-19) Pandemic: Is It Appropriate to Treat Patients in the Absence of Significant Evidence?

Abstract:

Link para artigo

Uric Acid Elevation by Favipiravir, an Antiviral Drug

Mishima E, Anzai N, Miyazaki M, Abe T.

Abstract:

Link para artigo

Potential for jaktinib hydrochloride to treat cytokine storms in patients with COVID-19

Meng X, Ling Y, Zhang L, Zhang Q, Dong P, Zhu T, Lu H.

Abstract:

Link para artigo

Roles and challenges of traditional Chinese medicine in COVID-19 in Hong Kong

Lin WL, Hon KL, Leung KKY, Lin ZX.

Abstract:

Link para artigo

Living evidence in response to controversies about the use of antimalarials in COVID-19

Santillán-García A, Bravo-Jeria R, Verdugo-Paiva F, Rada G.

Abstract:

Link para artigo

IL-15 immunotherapy is a viable strategy for COVID-19

Kandikattu HK, Venkateshaiah SU, Kumar S, Mishra A.

Abstract:

Link para artigo

Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?

Habtemariam S, Nabavi SF, Banach M, Berindan-Neagoe I, Sarkar K, Sil PC, Nabavi SM.

Abstract:

Link para artigo

Psychiatry and COVID-19: The Role of Chlorpromazine

Stip E.

Abstract:

Link para artigo

Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019

Kim JW, Kim EJ, Kwon HH, Jung CY, Kim KC, Choe JY, Hong HL.

Abstract:

Link para artigo

Critical Need for Implementation of Clinical Pharmacology Principles in Developing Drugs for the Treatment or Prevention of COVID-19

Pastino G.

Abstract:

Link para artigo

Cardiovascular Implications and Therapeutic Considerations in COVID-19 Infection

Judson GL, Kelemen BW, Njoroge JN, Mahadevan VS.

Abstract:

Link para artigo

IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy?

Atal S, Fatima Z.

Abstract:

Link para artigo

Combination of JAKinibs with Methotrexate or Anti-Cytokine Biologics in Patients with Severe COVID-19

Seif F, Pornour M, Mansouri D.

Abstract:

Link para artigo

Merits and culprits of immunotherapies for neurological diseases in times of COVID-19

Pawlitzki M, Zettl UK, Ruck T, Rolfes L, Hartung HP, Meuth SG.

Abstract:

Link para artigo

COVID-19, interferons, and depression: A commentary

Shader RI.

Abstract:

Link para artigo

Ibuprofen use and clinical outcomes in COVID-19 patients

Rinott E, Kozer E, Shapira Y, Bar-Haim A, Youngster I.

Abstract:

Link para artigo

Virtual screening, ADME/Tox predictions and the drug repurposing concept for future use of old drugs against the COVID-19

da Silva Hage-Melim LI, Federico LB, de Oliveira NKS, Francisco VCC, Correa LC, de Lima HB, Gomes SQ, Barcelos MP, Francischini IAG, de Paula da Silva CHT.

Abstract:

Link para artigo

Vaccination strategies to combat novel corona virus SARS-CoV-2

Pandey SC, Pande V, Sati D, Upreti S, Samant M.

Abstract:

Link para artigo

The lurking scourge of multidrug resistant Candida auris in times of COVID-19 pandemic

Chowdhary A, Sharma A.

Abstract:

Link para artigo

Vitamin D Receptor stimulation to reduce Acute Respiratory Distress Syndrome (ARDS) in patients with Coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166

Quesada-Gomez JM, Castillo ME, Bouillon R.

Abstract:

Link para artigo

Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced 'PANIC' attack

Frohman EM, Villemarette-Pittman NR, Cruz RA, Longmuir R, Rowe V, Rowe ES, Varkey TC, Steinman L, Zamvil SS, Frohman TC.

Abstract:

Link para artigo

COVID-19 vaccines for all?

Usher AD.

Abstract:

Link para artigo

COVID-19 Pandemic Hemoperfusion Therapy Versus Plasma Exchange Therapy in Intensive Care

Esmaeili Vardanjani A, Moayedi S, Golitaleb M.

Abstract:

Link para artigo

Management of COVID-19 Virus Infection by Convalescent Plasma

Cheraghali AM, Abolghasemi H, Eshghi P.

Abstract:

Link para artigo

Microdose lithium reduces cellular senescence in human astrocytes - a potential pharmacotherapy for COVID-19?

Viel T, Chinta S, Rane A, Chamoli M, Buck H, Andersen J.

Abstract:

Link para artigo

Hydroxychloroquine/ chloroquine as a treatment choice or prophylaxis for Covid-19 at the primary care level in developing countries: A Primum non Nocere dilemma

Chevalier MTM, Moncada SS.

Abstract:

Link para artigo

Diacerein: A potential multi-target therapeutic drug for COVID-19

de Oliveira PG, Termini L, Durigon EL, Lepique AP, Sposito AC, Boccardo E.

Abstract:

Link para artigo

Monoclonal antibody as a potential anti-COVID-19

Jahanshahlu L, Rezaei N.

Abstract:

Link para artigo

Macrolides and viral infections: focus on azithromycin in COVID-19 pathology

Pani A, Lauriola M, Romandini A, Scaglione F.

Abstract:

Link para artigo

Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2): A global pandemic and treatments strategies

Sharma A, Tiwari S, Deb MK, Marty JL.

Abstract:

Link para artigo

Three novel prevention, diagnostic, and treatment options for COVID-19 urgently necessitating controlled randomized trials

Horowitz RI, Freeman PR.

Abstract:

Link para artigo

EPO in Patients With COVID-19: More Than an Erythropoietic Hormone

Leventhal J, Angeletti A, Cravedi P.

Abstract:

Link para artigo

Antiviral activity of the high-molecular-weight plant polysaccharides (Panavir®)

Kalinina TS, Zlenko DV, Kiselev AV, Litvin AA, Stovbun SV.

Abstract:

Link para artigo

COVID-19 and allergen immunotherapy: theoretical benefits invite to adjustments in practice recommendations

Larenas-Linnemann D, Rodríguez-Pérez N, Ortega-Martell JA, Vijil VB, Luna-Pech JA; Mexican Immunotherapy Working Group.

Abstract:

Link para artigo

Guidance for the Procurement of COVID-19 Convalescent Plasma: Differences between High and Low-Middle Income Countries

Bloch EM, Goel R, Wendel S, Burnouf T, Al-Riyami AZ, Ang AL, DeAngelis V, Dumont LJ, Land K, Lee CK, Oreh A, Patidar G, Spitalnik SL, Vermeulen M, Hindawi S, Van den Berg K, Tiberghien P, Vrielink H, Young P, Devine D, So-Osman C; ISBT Convalescent Plasma Working Group.

Abstract:

Link para artigo

Further aspects of doxycycline therapy in COVID-19

Szolnoky G.

Abstract:

Link para artigo

Persistent viral RNA shedding after COVID-19 symptom resolution in older convalescent plasma donors

Hartman WR, Hess AS, Connor J.

Abstract:

Link para artigo

Azithromycin for COVID-19: More Than Just an Antimicrobial?

Bleyzac N, Goutelle S, Bourguignon L, Tod M.

Abstract:

Link para artigo

Intracellular ABCB1 as a Possible Mechanism to Explain the Synergistic Effect of Hydroxychloroquine-Azithromycin Combination in COVID-19 Therapy

Scherrmann JM.

Abstract:

Link para artigo

COVID-19 remedies

Abstract:

Link para artigo

Passive antibody therapy in COVID-19

Abraham J.

Abstract:

Link para artigo

Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen

Heidary F, Gharebaghi R.

Abstract:

Link para artigo

Clinical experience with therapeutic dose of Low-Molecular-Weight Heparin

Viale P, Bartoletti M.

Abstract:

Link para artigo

Multivalue ethical framework for fair global allocation of a COVID-19 vaccine

Liu Y, Salwi S, Drolet B.

Abstract:

Link para artigo

Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19

Accorsi P, Berti P, de Angelis V, De Silvestro G, Mascaretti L, Ostuni A; Italian Society for Transfusion Medicine Immunohaematology (SIMTI) Italian Society for Hemapheresis cell Manipulation (SIdEM).

Abstract:

Link para artigo

Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines

Shih HI, Wu CJ, Tu YF, Chi CY.

Abstract:

Link para artigo

Opportunities and challenges of traditional Chinese medicine going abroad for COVID-19 treatment

Huang XQ, Zhou MY, Cheng YR, Ye L, Wang MW, Chen J, Zhao LJ, Feng ZH.

Abstract:

Link para artigo

Effectiveness of corticoid pulses in patients with cytokine storm syndrome induced by SARS-CoV-2 infection

Callejas Rubio JL, Luna Del Castillo JD, de la Hera Fern√°ndez J, Guirao Arrabal E, Colmenero Ruiz M, Ortego Centeno N.

Abstract:

Link para artigo

Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II)

Ye Q, Wang H, Xia X, Zhou C, Liu Z, Xia ZE, Zhang Z, Zhao Y, Yehenala J, Wang S, Zhou G, Hu K, Wu B, Wu CT, Wang S, He Y.

Abstract:

Link para artigo

Interferon beta-1a for COVID-19: critical importance of the administration route

Jalkanen J, Hollmén M, Jalkanen S.

Abstract:

Link para artigo

The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner

Yamamoto M, Kiso M, Sakai-Tagawa Y, Iwatsuki-Horimoto K, Imai M, Takeda M, Kinoshita N, Ohmagari N, Gohda J, Semba K, Matsuda Z, Kawaguchi Y, Kawaoka Y, Inoue JI.

Abstract:

Link para artigo

Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19)

Yuan S, Chan CC, Chik KK, Tsang JO, Liang R, Cao J, Tang K, Cai JP, Ye ZW, Yin F, To KK, Chu H, Jin DY, Hung IF, Yuen KY, Chan JF.

Abstract:

Link para artigo

Prospects of Replication-Deficient Adenovirus Based Vaccine Development against SARS-CoV-2

Garofalo M, Staniszewska M, Salmaso S, Caliceti P, Pancer KW, Wieczorek M, Kuryk L.

Abstract:

Link para artigo

Impact of disease on plasma and lung exposure of chloroquine, hydroxy-chloroquine and azithromycin: application of PBPK modelling

Rowland Yeo K, Zhang M, Pan X, Ban Ke A, Jones HM, Wesche D, Almond LM.

Abstract:

Link para artigo

Serotonin syndrome in two COVID-19 patients treated with lopinavir/ritonavir

Mas Serrano M, Pérez-Sánchez JR, Portela Sánchez S, De La Casa-Fages B, Mato Jimeno V, Pérez Tamayo I, Grandas F.

Abstract:

Link para artigo

Is hesperidin essential for prophylaxis and treatment of COVID-19 Infection?

Haggag YA, El-Ashmawy NE, Okasha KM.

Abstract:

Link para artigo

Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?

Mohamed-Hussein AAR, Aly KME, Ibrahim MAA.

Abstract:

Link para artigo

East meets West in COVID-19 therapeutics

Wang S, Zeng X, Wang Y, Zhao Y, Chen W, Chen YZ.

Abstract:

Link para artigo

Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China

Pan X, Dong L, Yang N, Chen D, Peng C.

Abstract:

Link para artigo

Clinical course and treatment efficacy of COVID-19 near Hubei Province, China: a multicentre, retrospective study

Zeng QL, Li GM, Ji F, Ma SH, Zhang GF, Xu JH, Lin WB, Xu GH, Zhang GQ, Li GT, Cui GL, Liu N, Zeng FJ, Ai ZG, Xu GF, Liu N, Liang J, Zhang MM, Li C, Zhang ZH, Wang ZS, Li Z, Yu ZJ.

Abstract:

Link para artigo

Rapid Review: Nonsteroidal Anti-inflammatory Agents and Aminosalicylates in COVID-19 Infections

Ehrenpreis ED, Kruchko DH.

Abstract:

Link para artigo

Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: A case series

Mohtadi N, Ghaysouri A, Shirazi S, Sara Ansari, Shafiee E, Bastani E, Kokhazadeh T, Tavan H.

Abstract:

Link para artigo

Can steroids reverse the severe COVID-19 induced 'cytokine storm'?

Kolilekas L, Loverdos K, Giannakaki S, Vlassi L, Levounets A, Zervas E, Gaga M.

Abstract:

Link para artigo

Why your Patients' Believing Hydroxychloroquine and Chloroquine are 90% Effective for COVID-19 is 100% Dangerous

White CM, Hernandez AV.

Abstract:

Link para artigo

Convalescent Plasma and COVID-19

Malani AN, Sherbeck JP, Malani PN.

Abstract:

Link para artigo

New (re)Purpose for an old drug: purinergic receptor blockade may extinguish the COVID-19 thrombo-inflammatory firestorm

Kanthi Y, Knight JS, Zuo Y, Pinsky DJ.

Abstract:

Link para artigo

Lopinavir/ritonavir as a third agent in the antiviral regimen for SARS-CoV-2 infection

Panagopoulos P, Petrakis V, Panopoulou M, Trypsianis G, Penlioglou T, Pnevmatikos I, Papazoglou D.

Abstract:

Link para artigo

Can lactoferrin boost human immunity against COVID-19?

AlKhazindar M, Elnagdy SM.

Abstract:

Link para artigo

When a COVID-19 vaccine is ready, will we all be ready for it?

Fadda M, Albanese E, Suggs LS.

Abstract:

Link para artigo

Does Ibuprofen Worsen COVID-19?

Moore N, Carleton B, Blin P, Bosco-Levy P, Droz C.

Abstract:

Link para artigo

Statin therapy in COVID-19 infection: much more than a single pathway

Bifulco M, Gazzerro P.

Abstract:

Link para artigo

Adoption and impact of non-pharmaceutical interventions for COVID-19

Imai N, Gaythorpe KAM, Abbott S, Bhatia S, van Elsland S, Prem K, Liu Y, Ferguson NM.

Abstract:

Link para artigo

Broad beans (Vicia faba) and the potential to protect from COVID-19 coronavirus infection

Khalil MI, Salih MA, Mustafa AA.

Abstract:

Link para artigo

Perspectives on repositioning chloroquine and hydroxychloroquine for the treatment of Covid-19

Adeel AA.

Abstract:

Link para artigo

Holding CoVID in check through JAK? The MPN-approved compound ruxolitinib as a potential strategy to treat SARS-CoV-2 induced systemic hyperinflammation

Heidel F, Hochhaus A.

Abstract:

Link para artigo

Type I and III interferons disrupt lung epithelial repair during recovery from viral infection

Major J, Crotta S, Llorian M, McCabe TM, Gad HH, Priestnall SL, Hartmann R, Wack A.

Abstract:

Link para artigo

Type III interferons disrupt the lung epithelial barrier upon viral recognition

Broggi A, Ghosh S, Sposito B, Spreafico R, Balzarini F, Lo Cascio A, Clementi N, De Santis M, Mancini N, Granucci F, Zanoni I.

Abstract:

Link para artigo

Can existing live vaccines prevent COVID-19?

Chumakov K, Benn CS, Aaby P, Kottilil S, Gallo R.

Abstract:

Link para artigo

[Effect of Xuebijing injection on inflammatory markers and disease outcome of coronavirus disease 2019]

Wen L, Zhou Z, Jiang D, Huang K.

Abstract:

Link para artigo

[Clinical study of artesunate in the treatment of coronavirus disease 2019]

Lin Y, Wu F, Xie Z, Song X, Zhu Q, Wei J, Tan S, Liang L, Gong B.

Abstract:

Link para artigo

[Nationwide survey on clinical treatment of coronavirus disease 2019 in 9 provinces and municipalities]

Liu S, Ding X, Cao J, Zhang S, Sun T.

Abstract:

Link para artigo

Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients

Convertino I, Tuccori M, Ferraro S, Valdiserra G, Cappello E, Focosi D, Blandizzi C.

Abstract:

Link para artigo

Immunoinformatics and Structural Analysis for Identification of Immunodominant Epitopes in SARS-CoV-2 as Potential Vaccine Targets

Mukherjee S, Tworowski D, Detroja R, Mukherjee SB, Frenkel-Morgenstern M.

Abstract:

Link para artigo

Response to 'Vitamin D concentrations and COVID-19 infection in UK Biobank'

Roy AS, Matson M, Herlekar R.

Abstract:

Link para artigo

A potential role for cyclophosphamide in the mitigation of acute respiratory distress syndrome among patients with SARS-CoV-2

Revannasiddaiah S, Kumar Devadas S, Palassery R, Kumar Pant N, Maka VV.

Abstract:

Link para artigo

Use of hydroxychloroquine and interferon alpha-2b for the prophylaxis of COVID-19

Yang A, Yang C, Yang B.

Abstract:

Link para artigo

Dermatological therapies with relevance to COVID-19

Shishak M, Sarkar R.

Abstract:

Link para artigo

Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID-19

Yen BL, Yen ML, Wang LT, Liu KJ, Sytwu HK.

Abstract:

Link para artigo

Should we adapt the prescription criteria for specific treatments for migraine due to the Covid-19 pandemic?

Porta-Etessam J, Gonzalez-Garcia N, Matias-Guiu JA, Montero-Escribano P, Matías-Guiu J.

Abstract:

Link para artigo

Early safety indicators of COVID-19 convalescent plasma in 5,000 patients

Joyner MJ, Wright RS, Fairweather D, Senefeld JW, Bruno KA, Klassen SA, Carter RE, Klompas AM, Wiggins CC, Shepherd JR, Rea RF, Whelan ER, Clayburn AJ, Spiegel MR, Johnson PW, Lesser ER, Baker SE, Larson KF, Ripoll JG, Andersen KJ, Hodge DO, Kunze KL, Buras MR, Vogt MN, Herasevich V, Dennis JJ, Regimbal RJ, Bauer PR, Blair JE, van Buskirk CM, Winters JL, Stubbs JR, Paneth NS, Verdun NC, Marks P, Casadevall A.

Abstract:

Link para artigo

A vaccine is not too far for COVID-19

Patel SK, Pathak M, Tiwari R, Yatoo MI, Malik YS, Sah R, Rabaan AA, Sharun K, Dhama K, Bonilla-Aldana DK, Rodriguez-Morales AJ.

Abstract:

Link para artigo

Multigroup, Adaptively Randomized Trials Are Advantageous for Comparing Coronavirus Disease 2019 (COVID-19) Interventions

Magaret AS, Jacob ST, Halloran ME, Guthrie KA, Magaret CA, Johnston C, Simon NR, Wald A.

Abstract:

Link para artigo

The status surrounding chloroquine and other drugs as potential anti-infective agents for COVID-19

Ramotar D.

Abstract:

Link para artigo

Potential for elimination of SAR-CoV-2 through vaccination as inspired by elimination of multiple influenza viruses through natural pandemics or mass vaccination

Chen JM, Sun YX, Chen JW.

Abstract:

Link para artigo

The Dual Epidemics of COVID-19 and Influenza: Vaccine Acceptance, Coverage, and Mandates

Gostin LO, Salmon DA.

Abstract:

Link para artigo

Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19

Delaleu J, Deniau B, Battistella M, de Masson A, Bensaid B, Jachiet M, Lazaridou I, Bagot M, Bouaziz JD; Saint-Louis CORE (COvid REsearch) group.

Abstract:

Link para artigo

Lithium as a candidate treatment for COVID-19: Promises and pitfalls

Rajkumar RP.

Abstract:

Link para artigo

Practice considerations on the use of investigational anti-COVID-19 medications: Dosage, administration and monitoring

Kang JE, Rhie SJ.

Abstract:

Link para artigo

Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists' experiences with preventative measures and sources of information

Hoti K, Jakupi A, Hetemi D, Raka D, Hughes J, Desselle S.

Abstract:

Link para artigo

Effectiveness of Tocilizumab in a COVID-19 Patient with Cytokine Release Syndrome

Uslu S.

Abstract:

Link para artigo

A brief note on randomized controlled trials and compassionate/off-label use of drugs in the early phases of the COVID-19 pandemic

Bassetti M, Pelosi P, Robba C, Vena A, Giacobbe DR.

Abstract:

Link para artigo

Potential pro-arrhythmic effects of pharmacotherapy against SARS-CoV-2

Medeiros-Domingo A, Carrasco OF, Berni-Betancourt A.

Abstract:

Link para artigo

Biologics, spondylitis and COVID-19

Rosenbaum JT, Hamilton H, Choi D, Weisman MH, Reveille JD, Winthrop KL.

Abstract:

Link para artigo

Widely available lysosome targeting agents should be considered as a potential therapy for COVID-19

Homolak J, Kodvanj I.

Abstract:

Link para artigo

Treatment of SARS-CoV-2 with high dose oral zinc salts: A report on four patients

Finzi E.

Abstract:

Link para artigo

Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19?

Soliz J, Schneider-Gasser EM, Arias-Reyes C, Aliaga-Raduan F, Poma-Machicao L, Zubieta-Calleja G, Furuya WI, Trevizan-Ba√∫ P, Dhingra RR, Dutschmann M.

Abstract:

Link para artigo

Hydroxychloroquine-induced erythema multiforme in a patient with COVID-19

Monte Serrano J, Cruañes Monferrer J, García-García M, García-Gil MF.

Abstract:

Link para artigo

Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial

Sivapalan P, Ulrik CS, Bojesen RD, Lapperre TS, Eklöf JV, Håkansson KEJ, Browatzki A, Tidemansen C, Wilcke JT, Janner J, Gottlieb V, Meteran H, Porsbjerg C, Madsen BL, Moberg M, Pedersen L, Benfield TL, Lundgren JD, Knop FK, Biering-Sørensen T, Ghanizada M, Sonne TP, Bødtger UCS, Jensen SG, Rasmussen DB, Brøndum E, Tupper OD, Sørensen SW, Alstrup G, Laursen CB, Møller UW, Sverrild A, Jensen JS.

Abstract:

Link para artigo

Autophagy as an emerging target for COVID-19: lessons from an old friend, chloroquine

Bonam SR, Muller S, Bayry J, Klionsky DJ.

Abstract:

Link para artigo

Redox-Modulating Agents in the Treatment of Viral Infections

Checconi P, De Angelis M, Marcocci ME, Fraternale A, Magnani M, Palamara AT, Nencioni L.

Abstract:

Link para artigo

Structural basis of potential binding mechanism of remdesivir to SARS-CoV-2 RNA dependent RNA polymerase

Zhang L, Zhou R.

Abstract:

Link para artigo

Overview of Coronavirus Disease 2019 (COVID-19): Treatment Updates and Advances

Luo YH, Chiu HY, Weng CS, Chen YM.

Abstract:

Link para artigo

Review on the clinical pharmacology of hydroxychloroquine sulfate for the treatment of COVID-19

Cui C, Tu S, En VSJ, Li X, Yao X, Li H, Liu D.

Abstract:

Link para artigo

Re: "Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19" by Sengupta et al

Lim SK, Giebel B, Weiss DJ, Witwer KW, Rohde E.

Abstract:

Link para artigo

Response to Kim et al. re: "Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19"

Sengupta V, Sengupta S, Lazo A , Jr, Hicok KC, Moseley T.

Abstract:

Link para artigo

COVID-19 Pneumonia Mimicking Immunotherapy-Induced Pneumonitis on 18F-FDG PET/CT in a Patient Under Treatment With Nivolumab

Artigas C, Lemort M, Mestrez F, Gil T, Flamen P.

Abstract:

Link para artigo

Remdésivir et Covid-19: résultats négatifs mais méthode de recherche (enfin) appropriée !

Fumeaux T.

Abstract:

Link para artigo

Safety of drugs during previous and current coronavirus pandemics: Lessons for IBD

Sebastian S, Gonzalez HA, Peyrin-Biroulet L.

Abstract:

Link para artigo

Epidemiology, diagnosis, treatment, and future perspectives concerning SARS-COV-2: a review article

Carvalho ARVS, Cezarotti Filho ML, Azevedo PCP, Silveira Filho RN, Barbosa FT, Rocha TJM, Sousa-Rodrigues CF, Ramos FWDS.

Abstract:

Link para artigo

Traditional Chinese medicine practices used in COVID-19 (Sars-cov 2/Coronavirus-19) treatment in clinic and their effects on the cardiovascular system

Akalın E, Ekici M, Alan Z, Özbir Elevli E, Yaman Bucak A, Aobuliaikemu N, Üresin AY.

Abstract:

Link para artigo

COVID-19 in a severe eosinophilic asthmatic receiving benralizumab - a case study

Renner A, Marth K, Patocka K, Pohl W.

Abstract:

Link para artigo

Is targeting Akt a viable option to treat advanced-stage COVID-19 patients?

Somanath PR.

Abstract:

Link para artigo

Consideration of Pannexin 1 channels in COVID-19 pathology and treatment

Swayne LA, Johnstone SR, Ng CS, Sanchez-Arias JC, Good ME, Penuela S, Lohman AW, Wolpe AG, Laubach VE, Koval M, Isakson BE.

Abstract:

Link para artigo

The potential of cannabidiol in the COVID-19 pandemic: a hypothesis letter

Esposito G, Pesce M, Seguella L, Sanseverino W, Lu J, Corpetti C, Sarnelli G.

Abstract:

Link para artigo

Recommendations on trichological treatments during COVID-19 pandemic

Rossi A, Magri F, Caro G, Federico A, Di Fraia M, Muscianese M, Fortuna MC, Carlesimo M.

Abstract:

Link para artigo

Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics

Qin H, Zhao A.

Abstract:

Link para artigo

Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review

Patel TK, Barvaliya M, Kevadiya BD, Patel PB, Bhalla HL.

Abstract:

Link para artigo

BCG Vaccination Policy and Protection Against COVID-19

Meena J, Yadav A, Kumar J.

Abstract:

Link para artigo

What can we learn about corticosteroid therapy as a treatment for COVID-19?

Tang J.

Abstract:

Link para artigo

Caution and clarity required in the use of chloroquine for COVID-19

Wong YK, Yang J, He Y.

Abstract:

Link para artigo

Lithium and coronaviral infections. A scoping review

Nowak JK, Walkowiak J.

Abstract:

Link para artigo

Pay attention to situation of SARS-CoV-2 and TCM advantages in treatment of novel coronavirus infection

Liu CX.

Abstract:

Link para artigo

The hunt for covid-19 drugs

MacKenzie D.

Abstract:

Link para artigo

The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation

La Rosée F, Bremer HC, Gehrke I, Kehr A, Hochhaus A, Birndt S, Fellhauer M, Henkes M, Kumle B, Russo SG, La Rosée P.

Abstract:

Link para artigo

Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases

Dos Reis Neto ET, Kakehasi AM, de Medeiros Pinheiro M, Ferreira GA, Marques CDL, da Mota LMH, Dos Santos Paiva E, Pileggi GCS, Sato EI, Reis APMG, Xavier RM, Provenza JR.

Abstract:

Link para artigo

Early experience with convalescent plasma as immunotherapy for COVID-19 in China: Knowns and unknowns

Chen B, Xia R.

Abstract:

Link para artigo

B-cell engineering: A promising approach towards vaccine development for COVID-19

Faiq MA.

Abstract:

Link para artigo

Pulmonary delivery of nanostructured lipid carriers for effective repurposing of salinomycin as an antiviral agent

Pindiprolu SKSS, Kumar CSP, Kumar Golla VS, P L, K SC, S K EB, R K R.

Abstract:

Link para artigo

Additive treatment considerations in COVID-19 - the clinician´s perspective on extracorporeal adjunctive purification techniques

Swol J, Lorusso R.

Abstract:

Link para artigo

The quest to find an effective vaccine for COVID-19

Glasper A.

Abstract:

Link para artigo

Existing Drugs Might Treat COVID-19

Abbasi J.

Abstract:

Link para artigo

Higher levels of IL-6 early after tocilizumab distinguish survivors from non-survivors in COVID-19 pneumonia: a possible indication for deeper targeting IL-6

Quartuccio L, Sonaglia A, Pecori D, Peghin M, Fabris M, Tascini C, De Vita S.

Abstract:

Link para artigo

Treatment options in people with COVID19: Selecting the best armamentarium against the novel virus

Shaikh K, Shrestha C, Dutta D.

Abstract:

Link para artigo

Clinical features, diagnosis and management of COVID-19 patients in the outdoor setting

Jamil B.

Abstract:

Link para artigo

Personal prophylaxis against COVID-19: A compilation of evidence based recommendations

Verma M, Aydin H.

Abstract:

Link para artigo

[Isoflavones have therapeutic efficacy inoestrogen deficiency]

Hellfritzsch M, Kümler T, Hansen AT, Tang M, Berthelsen KG, Fialla AD, Andersen AS, Kampmann P, Hvas AM.

Abstract:

Link para artigo

[Remdesivir til behandling af COVID-19-pneumoni]

Benfiels T, Jensen T√ò, Johansen IS, Nielsen H, Wiese L, √òstergaard L, Lundgren J.

Abstract:

Link para artigo

A call for the appropriate application of clinical pharmacological principles in the search for safe and efficacious COVID-19 (SARS-COV-2) treatments

Baker EH, Gnjidic D, Kirkpatrick CMJ, Pirmohamed SM, Wright DFB, Zecharia AY.

Abstract:

Link para artigo

Drug-Induced Liver Injury and COVID-19 Infection: The Rules Remain the Same

Olry A, Meunier L, Délire B, Larrey D, Horsmans Y, Le Louët H.

Abstract:

Link para artigo

[Biological therapy after COVID-19 infection : No reactivation of a COVID-19 infection with positive SARS-CoV-2 antibody status under biological therapy]

Steinchen N, Müller-Ladner U, Lange U.

Abstract:

Link para artigo

Intentional Hydroxychloroquine Overdose Treated with High-Dose Diazepam: an Increasing Concern in the COVID-19 Pandemic

Chai PR, Ferro EG, Kirshenbaum JM, Hayes BD, Culbreth SE, Boyer EW, Erickson TB.

Abstract:

Link para artigo

The potential of drug repositioning as a short-term strategy for the control and treatment of COVID-19 (SARS-CoV-2): a systematic review

Lima WG, Brito JCM, Overhage J, Nizer WSDC.

Abstract:

Link para artigo

Hydroxychloroquine pharmacokinetic in COVID-19 critically ill patients: an observational cohort study

Painvin B, Guillot P, Verdier MC, Gacouin A, Maamar A.

Abstract:

Link para artigo

High-dose, short-term corticosteroids for ARDS caused by COVID-19: a case series

So C, Ro S, Murakami M, Imai R, Jinta T.

Abstract:

Link para artigo

Artesunate: could be an alternative drug to chloroquine in COVID-19 treatment?

Uzun T, Toptas O.

Abstract:

Link para artigo

Intensifying vaccine production

Abstract:

Link para artigo

COVID-19 vaccines start moving into advanced trials

Mullard A.

Abstract:

Link para artigo

First antibody against COVID-19 spike protein enters phase I

Mullard A.

Abstract:

Link para artigo

Covid-19: Hydroxychloroquine does not benefit hospitalised patients, UK trial finds

Torjesen I.

Abstract:

Link para artigo

Procedural sedation in the COVID-19 era

Fawley N, Abdelmalak B.

Abstract:

Link para artigo

What is the role of supplementation with ascorbic acid, zinc, vitamin D, or N-acetylcysteine for prevention or treatment of COVID-19?

Bauer SR, Kapoor A, Rath M, Thomas SA.

Abstract:

Link para artigo

Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19

Adamsick ML, Gandhi RG, Bidell MR, Elshaboury RH, Bhattacharyya RP, Kim AY, Nigwekar S, Rhee EP, Sise ME.

Abstract:

Link para artigo

Methotrexate based oral chemotherapy for advanced oral cancer during COVID-19 pandemic: Another option in the therapeutic armamentarium

Kaul P, Singh MP, Pasricha R, Garg PK.

Abstract:

Link para artigo

Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial

Eckhardt CM, Cummings MJ, Rajagopalan KN, Borden S, Bitan ZC, Wolf A, Kantor A, Briese T, Meyer BJ, Jacobson SD, Scotto D, Mishra N, Philip NM, Stotler BA, Schwartz J, Shaz B, Spitalnik SL, Eisenberg A, Hod EA, Justman J, Cheung K, Lipkin WI, O'Donnell MR.

Abstract:

Link para artigo

Efficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019- a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trial

Zhang C, Li J, Wu Z, Wang H, Que C, Zhao H, Wang G.

Abstract:

Link para artigo

A pilot study of therapeutic plasma exchange for serious SARS CoV-2 disease (COVID-19): A structured summary of a randomized controlled trial study protocol

Faqihi F, Alharthy A, Alodat M, Asad D, Aletreby W, Kutsogiannis DJ, Brindley PG, Karakitsos D.

Abstract:

Link para artigo

The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial

Chaccour C, Ruiz-Castillo P, Richardson MA, Moncunill G, Casellas A, Carmona-Torre F, Giráldez M, Mota JS, Yuste JR, Azanza JR, Fernández M, Reina G, Dobaño C, Brew J, Sadaba B, Hammann F, Rabinovich R.

Abstract:

Link para artigo

Blocking mineralocorticoid receptor with spironolactone may have a wide range of therapeutic actions in severe COVID-19 disease

Liaudet L, Szabo C.

Abstract:

Link para artigo

Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial

Calderón JM, Zerón HM, Padmanabhan S.

Abstract:

Link para artigo

From COVID-19 research to vaccine application: why might it take 17‚Äâmonths not 17‚Äâyears and what are the wider lessons?

Hanney SR, Wooding S, Sussex J, Grant J.

Abstract:

Link para artigo

Selenium supplementation can relieve the clinical complications of COVID-19 and other similar viral infections

Fakhrolmobasheri M, Nasr-Esfahany Z, Khanahmad H, Zeinalian M.

Abstract:

Link para artigo

From Wuhan to COVID-19 Pandemic: An Up-to-Date Review of Its Pathogenesis, Potential Therapeutics, and Recent Advances

Zeouk I, Bekhti K, Lorenzo-Morales J.

Abstract:

Link para artigo

Challenges in the Production of Convalescent Hyperimmune Plasma in the Age of COVID-19

Franchini M, Del Fante C, Klersy C, Glingani C, Percivalle E, Baldanti F, Perotti C.

Abstract:

Link para artigo

Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe

Flaxman S, Mishra S, Gandy A, Unwin HJT, Mellan TA, Coupland H, Whittaker C, Zhu H, Berah T, Eaton JW, Monod M; Imperial College COVID-19 Response Team, Ghani AC, Donnelly CA, Riley SM, Vollmer MAC, Ferguson NM, Okell LC, Bhatt S.

Abstract:

Link para artigo

Potential role of zinc supplementation in prophylaxis and treatment of COVID-19

Kumar A, Kubota Y, Chernov M, Kasuya H.

Abstract:

Link para artigo

Ketogenic diet therapy provision in the COVID-19 pandemic: Dual-center experience and recommendations

Kossoff EH, Turner Z, Adams J, Bessone SK, Avallone J, McDonald TJW, Diaz-Arias L, Barron BJ, Vizthum D, Cervenka MC.

Abstract:

Link para artigo

Mitigating Coronavirus-Induced Acute Respiratory Distress Syndrome by Radiotherapy

Li JJ.

Abstract:

Link para artigo

Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease

Gommans DHF, Nas J, Pinto-Sietsma SJ, Koop Y, Konst RE, Mensink F, Aarts GWA, Konijnenberg LSF, Cortenbach K, Verhaert DVM, Thannhauser J, Mol JQ, Rooijakkers MJP, Vos JL, van Rumund A, Vart P, Hassing RJ, Cornel JH, de Jager CPC, van den Heuvel MM, van der Hoeven HG, Verbon A, Pinto YM, van Royen N, van Kimmenade RRJ; Event committee, de Leeuw PW, van Agtmael MA, Bresser P; Data Safety Monitoring Board, van Gilst WH, Vonk-Noordergraaf A, Tijssen JGP; Steering committee, van Royen N, de Jager CP

Abstract:

Link para artigo

COVID-19 in rheumatic disease patients on immunosuppressive agents

Sharmeen S, Elghawy A, Zarlasht F, Yao QP.

Abstract:

Link para artigo

Early administered antibiotics do not impact mortality in critically ill patients with COVID-19

Buetti N, Mazzuchelli T, Priore EL, Balmelli C, Llamas M, Pallanza M, Elzi L, Consonni V, Trimboli P, Forni-Ogna V, Bernasconi E.

Abstract:

Link para artigo

Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

Mehra MR, Ruschitzka F, Patel AN.

Abstract:

Link para artigo

COVID-19: Drug targets and potential treatments

Gil C, Ginex T, Maestro I, Nozal V, Barrado-Gil L, Cuesta-Geijo MA, Urquiza J, Ramírez D, Alonso C, Campillo NE, Martínez A.

Abstract:

Link para artigo

Predictions of Systemic, Intracellular, and Lung Concentrations of Azithromycin with Different Dosing Regimens used in COVID-19 Clinical Trials

Hughes JH, Sweeney K, Ahadieh S, Ouellet D.

Abstract:

Link para artigo

Aerosol treatments for childhood asthma in the era of COVID-19

Mei-Zahav M, Amirav I.

Abstract:

Link para artigo

Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19

Gelincik A, Brockow K, Çelik GE, Doña I, Mayorga L, Romano A, Soyer Ö, Atanaskovic-Markovic M, Barbaud A, Torres MJ.

Abstract:

Link para artigo

Colchicine and COVID-19

Corral P, Corral G, Diaz R.

Abstract:

Link para artigo

COVID-19: from epidemiology to treatment

Pericàs JM, Hernandez-Meneses M, Sheahan TP, Quintana E, Ambrosioni J, Sandoval E, Falces C, Marcos MA, Tuset M, Vilella A, Moreno A, Miro JM; Hospital Clínic Cardiovascular Infections Study Group.

Abstract:

Link para artigo

Use of RAAS inhibitors and risk of clinical deterioration in COVID-19: results from an Italian cohort of 133 hypertensives

Felice C, Nardin C, Di Tanna GL, Grossi U, Bernardi E, Scaldaferri L, Romagnoli M, Tonon L, Cavasin P, Novello S, Scarpa R, Farnia A, De Menis E, Rigoli R, Cinetto F, Pauletto P, Agostini C, Rattazzi M.

Abstract:

Link para artigo

Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19

Magagnoli J, Narendran S, Pereira F, Cummings T, Hardin JW, Sutton SS, Ambati J.

Abstract:

Link para artigo

Effect of non-pharmaceutical interventions for containing the COVID-19 outbreak in China

Lai S, Ruktanonchai NW, Zhou L, Prosper O, Luo W, Floyd JR, Wesolowski A, Santillana M, Zhang C, Du X, Yu H, Tatem AJ.

Abstract:

Link para artigo

The impact of long-term non-pharmaceutical interventions on COVID-19 epidemic dynamics and control

Childs ML, Kain MP, Kirk D, Harris M, Couper L, Nova N, Delwel I, Ritchie J, Mordecai EA.

Abstract:

Link para artigo

Treatment of COVID-19 Patients with Convalescent Plasma in Houston, Texas

Salazar E, Perez KK, Ashraf M, Chen J, Castillo B, Christensen PA, Eubank T, Bernard DW, Eagar TN, Long SW, Subedi S, Olsen RJ, Leveque C, Schwartz MR, Dey M, Chavez-East C, Rogers J, Shehabeldin A, Joseph D, Williams G, Thomas K, Masud F, Talley C, Dlouhy KG, Lopez BV, Hampton C, Lavinder J, Gollihar JD, Maranhao AC, Ippolito GC, Saavedra MO, Cantu CC, Yerramilli P, Pruitt L, Musser JM.

Abstract:

Link para artigo

How Efficacious Must a COVID-19 Coronavirus Vaccine be to Prevent or Stop an Epidemic by Itself

Bartsch SM, O'Shea KJ, Ferguson MC, Bottazzi ME, Cox SN, Strych U, McKinnell JA, Wedlock PT, Siegmund SS, Hotez PJ, Lee BY.

Abstract:

Link para artigo

Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients

Joyner M, Wright RS, Fairweather D, Senefeld J, Bruno K, Klassen S, Carter R, Klompas A, Wiggins C, Shepherd JR, Rea R, Whelan E, Clayburn A, Spiegel M, Johnson P, Lesser E, Baker S, Larson K, Ripoll Sanz J, Andersen K, Hodge D, Kunze K, Buras M, Vogt M, Herasevich V, Dennis J, Regimbal R, Bauer P, Blair J, van Buskirk C, Winters J, Stubbs J, Paneth N, Casadevall A.

Abstract:

Link para artigo

Rapid generation of neutralizing antibody responses in COVID-19 patients

Suthar MS, Zimmerman M, Kauffman R, Mantus G, Linderman S, Vanderheiden A, Nyhoff L, Davis C, Adekunle S, Affer M, Sherman M, Reynolds S, Verkerke H, Alter DN, Guarner J, Bryksin J, Horwath M, Arthur C, Saakadze N, Smith GH, Edupuganti S, Scherer EM, Hellmeister K, Cheng A, Morales JA, Neish AS, Stowell SR, Frank F, Ortlund E, Anderson E, Menachery V, Rouphael N, Metha A, Stephens DS, Ahmed R, Roback J, Wrammert J.

Abstract:

Link para artigo

Association of Vitamin D Deficiency and Treatment with COVID-19 Incidence

Meltzer DO, Best TJ, Zhang H, Vokes T, Arora V, Solway J.

Abstract:

Link para artigo

Assessment of Hydroxychloroquine and Chloroquine Safety Profiles: A Systematic Review and Meta-Analysis

Ren L, Xu W, Overton JL, Yu S, Chiamvimonvat N, Thai PN.

Abstract:

Link para artigo

Protocol of a randomized controlled trial testing inhaled Nitric Oxide in mechanically ventilated patients with severe acute respiratory syndrome in COVID-19 (SARS-CoV-2)

Lei C, Su B, Dong H, Bellavia A, Di Fenza R, Safaee Fakhr B, Gianni S, Grassi LG, Kacmarek R, Araujo Morais CC, Pinciroli R, Vassena E, Berra L.

Abstract:

Link para artigo

Investigational treatments for COVID-19 may increase ventricular arrhythmia risk through drug interactions

Varshneya M, Irurzun-Arana I, Campana C, Dariolli R, Gutierrez A, Pullinger TK, Sobie EA.

Abstract:

Link para artigo

Repurposing Existing Medications for Coronavirus Disease 2019: Protocol for a Rapid and Living Systematic Review

Geisler BP, Zahabi L, Lang AE, Eastwood N, Tennant E, Lukic L, Sharon E, Chuang HH, Kang CB, Clayton-Johnson K, Aljaberi A, Yu H, Bui C, Mau TL, Li WC, Teodorescu D, Hinske LC, Sun DL, Manian FA, Dunn AG.

Abstract:

Link para artigo

Protocol for a randomized controlled trial testing inhaled nitric oxide therapy in spontaneously breathing patients with COVID-19

Lei C, Su B, Dong H, Fakhr BS, Grassi LG, Di Fenza R, Gianni S, Pinciroli R, Vassena E, Morais CCA, Bellavia A, Spina S, Kacmarek R, Berra L.

Abstract:

Link para artigo

Single-dose replicating RNA vaccine induces neutralizing antibodies against SARS-CoV-2 in nonhuman primates

Erasmus JH, Khandhar AP, Walls AC, Hemann EA, O'Connor MA, Murapa P, Archer J, Leventhal S, Fuller J, Lewis T, Draves KE, Randall S, Guerriero KA, Duthie MS, Carter D, Reed SG, Hawman DW, Feldmann H, Gale M Jr, Veesler D, Berglund P, Fuller DH.

Abstract:

Link para artigo

Remdesivir potently inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice

Pruijssers AJ, George AS, Schäfer A, Leist SR, Gralinksi LE, Dinnon KH, Yount BL, Agostini ML, Stevens LJ, Chappell JD, Lu X, Hughes TM, Gully K, Martinez DR, Brown AJ, Graham RL, Perry JK, Du Pont V, Pitts J, Ma B, Babusis D, Murakami E, Feng JY, Bilello JP, Porter DP, Cihlar T, Baric RS, Denison MR, Sheahan TP.

Abstract:

Link para artigo

A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation

Muruato AE, Fontes-Garfias CR, Ren P, Garcia-Blanco MA, Menachery VD, Xie X, Shi PY.

Abstract:

Link para artigo

Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease

Ma C, Sacco MD, Hurst B, Townsend JA, Hu Y, Szeto T, Zhang X, Tarbet B, Marty MT, Chen Y, Wang J.

Abstract:

Link para artigo

A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals

Riva L, Yuan S, Yin X, Martin-Sancho L, Matsunaga N, Burgstaller-Muehlbacher S, Pache L, De Jesus PP, Hull MV, Chang M, Chan JF, Cao J, Poon VK, Herbert K, Nguyen TT, Pu Y, Nguyen C, Rubanov A, Martinez-Sobrido L, Liu WC, Miorin L, White KM, Johnson JR, Benner C, Sun R, Schultz PG, Su A, Garcia-Sastre A, Chatterjee AK, Yuen KY, Chanda SK.

Abstract:

Link para artigo

COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning

Ong E, Wong MU, Huffman A, He Y.

Abstract:

Link para artigo

Azithromycin and ciprofloxacin have a chloroquine-like effect on respiratory epithelial cells

Poschet JF, Perkett EA, Timmins GS, Deretic V.

Abstract:

Link para artigo

Computational Models Identify Several FDA Approved or Experimental Drugs as Putative Agents Against SARS-CoV-2

Bobrowski T, Alves V, Melo-Filho CC, Korn D, Auerbach SS, Schmitt C, Muratov E, Tropsha A.

Abstract:

Link para artigo

Shotgun drug repurposing biotechnology to tackle epidemics and pandemics

Mangione W, Falls Z, Melendy T, Chopra G, Samudrala R.

Abstract:

Link para artigo

Omalizumab and COVID19 Treatment: Could It Help?

Abdelmaksoud A, Goldust M, Vestita M.

Abstract:

Link para artigo

The Application Of Plasmapheresis For Covid-19 Patients

Turgutkaya A, Yavasoglu I, Bolaman Z.

Abstract:

Link para artigo

Azithromycin and COVID-19Prompt Early Use at First Signs of this Infection in Adults and Children An Approach Worthy of Consideration

Schwartz RA, Suskind RM.

Abstract:

Link para artigo

Intramatricial methotrexate for treatment of resistant acrodermatitis continua of Hallopeau: an alterative in Covid-19

Jindal A, Ramesh S, Noronha M, Pai K, Pai S.

Abstract:

Link para artigo

Fast Identification of Possible Drug Treatment of Coronavirus Disease -19 (COVID-19) Through Computational Drug Repurposing Study

Wang J.

Abstract:

Link para artigo

Status of a real-life cohort of patients with moderate-to-severe plaque psoriasis treated with secukinumab and considerations on the use of biological agents in the Covid-19 era

Galluzzo M, Tofani L, Bianchi L, Talamonti M.

Abstract:

Link para artigo

A study on clinical effect of Arbidol combined with adjuvant therapy on COVID-19

Chen W, Yao M, Fang Z, Lv X, Deng M, Wu Z.

Abstract:

Link para artigo

α-glucosidase inhibitors as host-directed antiviral agents with potential for the treatment of COVID-19

Williams SJ, Goddard-Borger ED.

Abstract:

Link para artigo

Certainty of success: three critical parameters in coronavirus vaccine development

Kaslow DC.

Abstract:

Link para artigo

Effectiveness and safety of available treatments for COVID-19 during pregnancy: a critical review

Favilli A, Mattei Gentili M, Raspa F, Giardina I, Parazzini F, Vitagliano A, Borisova AV, Gerli S.

Abstract:

Link para artigo

Thalidomide combined with low-dose short-term glucocorticoid in the treatment of critical Coronavirus Disease 2019

Chen C, Qi F, Shi K, Li Y, Li J, Chen Y, Pan J, Zhou T, Lin X, Zhang J, Luo Y, Li X, Xia J.

Abstract:

Link para artigo

Routine antiemetic prophylaxis with dexamethasone during COVID-19: Should oncologists reconsider?

Marinella MA.

Abstract:

Link para artigo

Interpretation of the Traditional Chinese Medicine portion of the diagnosis and treatment protocol for corona virus disease 2019 (Trial Version 7)

Song P, Zhao L, Li X, Su J, Jiang Z, Song B, Liu W, Tang S, Lei Y, Ding Q, Yang Z, Lin J, Wei Y, Tong X.

Abstract:

Link para artigo

Effect of Jinhua Qinggan granules on novel coronavirus pneumonia in patients

Liu Z, Li X, Gou C, Li L, Luo X, Zhang C, Zhang Y, Zhang J, Jin A, Li H, Zeng Y, Li T, Wang X.

Abstract:

Link para artigo

No current evidence supporting risk of using Ibuprofen in patients with COVID-19

Martins-Filho PR, do Nascimento-J√∫nior EM, Santana Santos V.

Abstract:

Link para artigo

Drugs being investigated for children with COVID-19

Deniz M, Tapısız A, Tezer H.

Abstract:

Link para artigo

Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19

Solerte SB, Di Sabatino A, Galli M, Fiorina P.

Abstract:

Link para artigo

Use of Remdesivir in the Management of COVID-19: A Systematic Review on Current Evidences

Nasir M, Talha KA, Islam T, Saha SK, Selina F, Parveen RA.

Abstract:

Link para artigo

Antibiotic consumption may be linked to exaggeration of COVID-19

Asaduzzaman M, Zaman F, Rousham E.

Abstract:

Link para artigo

Ursodeoxycholic acid as a candidate therapeutic to alleviate and/or prevent COVID-19-associated cytokine storm

Abdulrab S, Al-Maweri S, Halboub E.

Abstract:

Link para artigo

The use of ibuprofen to treat fever in COVID-19: A possible indirect association with worse outcome?

Jamerson BD, Haryadi TH.

Abstract:

Link para artigo

Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?

Huang Y, Xie C, Chen X, Hong Q, Huang H.

Abstract:

Link para artigo

Effect Of Almitrine Bismesylate And Inhaled Nitric Oxide On Oxygenation In Covid-19 Acute Respiratory Distress Syndrome

Cardinale M, Esnault P, Cotte J, Cungi PJ, Goutorbe P.

Abstract:

Link para artigo

Radiotherapy for COVID-19: Primum non nocere

Boon IS, Yong TPTA, Boon CS.

Abstract:

Link para artigo

Response Letter: Radiation therapy for COVID-19 pneumopathy

Kirsch DG, Diehn M, Cucinotta FA, Weichselbaum R.

Abstract:

Link para artigo

Positive Outcome in a COVID-19 patient with Common Variable Immunodeficiency after IVIG

Aljaberi R, Wishah K.

Abstract:

Link para artigo

Battle against COVID-19: Efficacy of Convalescent Plasma as an emergency therapy

Kumar S, Sharma V, Priya K.

Abstract:

Link para artigo

To-go medications as a means to treat discharged emergency department patients during COVID-19

Molina MF, Chary AN, Baugh JJ, Ludy S, Ginart P, Dadabhoy FZ, Samuels-Kalow ME, Slutzman JE, Raja AS, Hayes BD.

Abstract:

Link para artigo

Cyclosporine as preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infection

Kemmner S, Guba M, Schönermarck U, Stangl M, Fischereder M.

Abstract:

Link para artigo

Investigate Oral Zinc as a Prophylactic Treatment for Those at Risk for COVID-19

McPherson SW, Keunen JE, Bird AC, Chew EY, van Kuijk FJ.

Abstract:

Link para artigo

COVID-19 vaccine development pipeline gears up

Mullard A.

Abstract:

Link para artigo

Nebulized Lidocaine in COVID-19, An Hypothesis

Ali ZA, El-Mallakh RS.

Abstract:

Link para artigo

Hydrogen peroxide and viral infections: A literature review with research hypothesis definition in relation to the current covid-19 pandemic

Caruso AA, Del Prete A, Lazzarino AI.

Abstract:

Link para artigo

N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2

Poe FL, Corn J.

Abstract:

Link para artigo

Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications

Banu N, Panikar SS, Leal LR, Leal AR.

Abstract:

Link para artigo

Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

The Lancet Editors.

Abstract:

Link para artigo

COVID-19 research: toxicological input urgently needed!

Esser C, Hochrath K, Schikowski T, Haarmann-Stemmann T.

Abstract:

Link para artigo

Inhibition of Bruton tyrosine kinase in patients with severe COVID-19

Roschewski M, Lionakis MS, Sharman JP, Roswarski J, Goy A, Monticelli MA, Roshon M, Wrzesinski SH, Desai JV, Zarakas MA, Collen J, Rose K, Hamdy A, Izumi R, Wright GW, Chung KK, Baselga J, Staudt LM, Wilson WH.

Abstract:

Link para artigo

Efficacy of remdesivir in patients with COVID-19: a protocol for systematic review and meta-analysis of randomised controlled trials

Gebrie D, Getnet D, Manyazewal T.

Abstract:

Link para artigo

Candidate rheumatologic treatments for COVID-19. Response to: 'COVID-19 infection in a patient with FMF: does colchicine have a protective effect?' by Kobak

Monti S, Montecucco C.

Abstract:

Link para artigo

COVID-19 infection in a patient with FMF: does colchicine have a protective effect?

Kobak S.

Abstract:

Link para artigo

Response to: 'Severe COVID-19 associated pneumonia in 3 patients with systemic sclerosis treated with rituximab' by Avouac et al

Guilpain P, Le Bihan C, Foulongne V, Taourel P, Pansu N, Maria ATJ, Jung B, Larcher R, Klouche K, Le Moing V.

Abstract:

Link para artigo

Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research

Bimonte S, Crispo A, Amore A, Celentano E, Cuomo A, Cascella M.

Abstract:

Link para artigo

Oral Methioninase for Covid-19 Methionine-restriction Therapy

Hoffman RM, Han Q.

Abstract:

Link para artigo

COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2

Andreou A, Trantza S, Filippou D, Sipsas N, Tsiodras S.

Abstract:

Link para artigo

Covid-19: Hydroxychloroquine was ineffective as postexposure prophylaxis, study finds

Mahase E.

Abstract:

Link para artigo

Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial

Bosteels C, Maes B, Van Damme K, De Leeuw E, Declercq J, Delporte A, Demeyere B, Vermeersch S, Vuylsteke M, Willaert J, Bollé L, Vanbiervliet Y, Decuypere J, Libeer F, Vandecasteele S, Peene I, Lambrecht B.

Abstract:

Link para artigo

Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial

Lyngbakken MN, Berdal JE, Eskesen A, Kvale D, Olsen IC, Rangberg A, Jonassen CM, Omland T, R√∏sj√∏ H, Dalgard O.

Abstract:

Link para artigo

The Mechanism and Clinical Outcome of patients with Corona Virus Disease 2019 Whose Nucleic Acid Test has changed from negative to positive, and the therapeutic efficacy of Favipiravir: A structured summary of a study protocol for a randomised controlled trial

Li J, Zhang C, Wu Z, Wang G, Zhao H.

Abstract:

Link para artigo

Angiotensin II administration to COVID-19 patients is not advisable

Speth RC.

Abstract:

Link para artigo

Adding Colchicine to the Antiretroviral Medication - Lopinavir/Ritonavir (Kaletra) in Hospitalized Patients with Non-Severe Covid-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomized Controlled Trial

Dalili N, Kashefizadeh A, Nafar M, Poorrezagholi F, Firouzan A, Samadian F, Samavat S, Ziaie S, Fatemizadeh S.

Abstract:

Link para artigo

Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials

Ten Doesschate T, Moorlag SJCFM, van der Vaart TW, Taks E, Debisarun P, Ten Oever J, Bleeker-Rovers CP, Verhagen PB, Lalmohamed A, Ter Heine R, van Crevel R, van de Wijgert J, Janssen AB, Bonten MJ, van Werkhoven CH, Netea MG; BCG-CORONA study team#.

Abstract:

Link para artigo

Homeopathic Clinical Features of 18 Patients in COVID-19 Outbreaks in Hong Kong

To KLA, Fok YYY.

Abstract:

Link para artigo

Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial

Lopes RD, Macedo AVS, de Barros E Silva PGM, Moll-Bernardes RJ, Feldman A, D'Andréa Saba Arruda G, de Souza AS, de Albuquerque DC, Mazza L, Santos MF, Salvador NZ, Gibson CM, Granger CB, Alexander JH, de Souza OF; BRACE CORONA investigators.

Abstract:

Link para artigo

Convalescent plasma therapy in the treatment of COVID-19: practical considerations: Correspondence

Islam A, Rafiq S, Karim S, Laher I, Rashid H.

Abstract:

Link para artigo

Potential role of statins in COVID-19

Lee KCH, Sewa DW, Phua GC.

Abstract:

Link para artigo

Optimising effectiveness of health care and value of clinical trials in the COVID -19 outbreak

Filippis G.

Abstract:

Link para artigo

Databases for facilitating mechanistic investigations of traditional Chinese medicines against COVID-19

Jiang S, Cui Q, Ni B, Chen Y, Tan Y, Chen W, Chen YZ.

Abstract:

Link para artigo

Tocilizumab administration in a refractory case of COVID-19

Dastan F, Nadji SA, Saffaei A, Tabarsi P.

Abstract:

Link para artigo

Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence

Turgeon RD, Zieroth S, Bewick D, Chow CM, Clarke B, Cowan S, Fordyce CB, Fournier A, Gin K, Gupta A, Hardiman S, Jackson S, Lau B, Leong-Poi H, Mansour S, Marelli A, Quraishi AR, Roifman I, Ruel M, Sapp J, Singh G, Small G, Virani S, Wood DA, Krahn A.

Abstract:

Link para artigo

Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study

Davies NG, Kucharski AJ, Eggo RM, Gimma A, Edmunds WJ; Centre for the Mathematical Modelling of Infectious Diseases COVID-19 working group.

Abstract:

Link para artigo

Rheumatic diseases during pregnancy and SARS-CoV-2: An appeal for medication adherence

Scioscia M, Praino E, Scioscia C.

Abstract:

Link para artigo

Angiotensin-converting enzyme inhibitors, angiotensin II type 1 receptor blockers and risk of COVID 19: information from Bartter's and Gitelman's syndromes patients

Calò LA, Davis PA, Rigato M, Sgarabotto L.

Abstract:

Link para artigo

The effect of massage on the quality of life in patients recovering from COVID-19: A systematic review protocol

Wu L, Dong Y, Li J, Huang J, Wen D, Peng T, Luo J.

Abstract:

Link para artigo

Efficacy and safety of Lian-Hua Qing-Wen granule for COVID-2019: A protocol for systematic review and meta-analysis

Hu Z, Yang M, Xie C.

Abstract:

Link para artigo

Aquagenic Syringeal Acrokeratoderma from Extensive Water Immersion during the COVID-19 Pandemic Outbreak

Kazandjieva J, Tsankov N, Darlenski R.

Abstract:

Link para artigo

Psoriasis-COVID 19 Infection: Treatment Options

Tampouratzi E, Kanni T, Katsantonis J, Douvali T.

Abstract:

Link para artigo

Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19

Mazzanti A, Briani M, Kukavica D, Bulian F, Marelli S, Trancuccio A, Monteforte N, Manciulli T, Morini M, Carlucci A, Viggiani G, Cannata F, Negri S, Bloise R, Memmi M, Gambelli P, Carbone A, Molteni M, Bianchini R, Salgarello R, Sozzi S, De Cata P, Fanfulla F, Ceriana P, Locatelli C, Napolitano C, Chiovato L, Tomasi L, Stefanini G, Condorelli G, Priori SG.

Abstract:

Link para artigo

Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621

Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN.

Abstract:

Link para artigo

Can Hypericum perforatum (SJW) prevent cytokine storm in COVID-19 patients?

Masiello P, Novelli M, Beffy P, Menegazzi M.

Abstract:

Link para artigo

A comparative study on the time to achieve negative nucleic acid testing and hospital stays between Danoprevir and Lopinavir/Ritonavir in the treatment of patients with COVID-19

Zhang Z, Wang S, Tu X, Peng X, Huang Y, Wang L, Ju W, Rao J, Li X, Zhu D, Sun H, Chen H.

Abstract:

Link para artigo

How to Rapidly Determine First-in-Children Dosing for COVID-19 Therapeutics

Watt KM.

Abstract:

Link para artigo

Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients With Coronavirus Disease 2019

Maharaj AR, Wu H, Hornik CP, Balevic SJ, Hornik CD, Smith PB, Gonzalez D, Zimmerman KO, Benjamin DK Jr, Cohen-Wolkowiez M; Best Pharmaceuticals for Children Act–Pediatric Trials Network Steering Committee.

Abstract:

Link para artigo

Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study

Cavalli G, De Luca G, Campochiaro C, Della-Torre E, Ripa M, Canetti D, Oltolini C, Castiglioni B, Tassan Din C, Boffini N, Tomelleri A, Farina N, Ruggeri A, Rovere-Querini P, Di Lucca G, Martinenghi S, Scotti R, Tresoldi M, Ciceri F, Landoni G, Zangrillo A, Scarpellini P, Dagna L.

Abstract:

Link para artigo

Response to: Broadbent 2020, Better the drug you know: Commentary on "Daughton 2020, Natural experiment concept to accelerate the re-purposing of existing therapeutics for Covid-19"

Daughton CG.

Abstract:

Link para artigo

Chloroquine dosage regimens in patients with COVID-19: Safety risks and optimization using simulations

Karalis V, Ismailos G, Karatza E.

Abstract:

Link para artigo

Angiotensin converting enzyme 2 (ACE2) and COVID-19: using antihypertensive medications, pharmacogenetic considerations

Snyder EM, Johnson BD.

Abstract:

Link para artigo

Vaccine repurposing approach for preventing COVID 19: can MMR vaccines reduce morbidity and mortality?

Anbarasu A, Ramaiah S, Livingstone P.

Abstract:

Link para artigo

Novel Coronavirus disease 2019 (COVID-19): new challenges and new responsibilities in developing countries

Anjum FR, Anam S, Rahman SU.

Abstract:

Link para artigo

Home delivery of medication during Coronavirus disease 2019, Cape Town, South Africa: Short report

Brey Z, Mash R, Goliath C, Roman D.

Abstract:

Link para artigo

Doubtful precipitation of hemolysis by hydroxychloroquine in glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection

Afra TP, Nampoothiri RV, Razmi T M.

Abstract:

Link para artigo

Considerations on Biologicals for Patients with allergic disease in times of the COVID-19 pandemic: an EAACI Statement

Vultaggio A, Agache I, Akdis CA, Akdis M, Bavbek S, Bossios A, Bousquet J, Boyman O, Chaker AM, Chan S, Chatzipetrou A, Feleszko W, Firinu D, Jutel M, Kauppi P, Klimek L, Kolios A, Kothari A, Kowalski ML, Matucci A, Palomares O, Pfaar O, Rogala B, Untersmayr E, Eiwegger T.

Abstract:

Link para artigo

COVID-19 and heme oxygenase: novel insight into the disease and potential therapies

Hooper PL.

Abstract:

Link para artigo

Balneotherapy in the era of COVID-19: should it be recommended or not?

Guvener O.

Abstract:

Link para artigo

Severe exacerbation of immune thrombocytopenia and COVID-19: the favorable response to corticosteroid-based therapy-a case report

Hu Z, Chen W, Liang W, Xu C, Sun W, Yi Y.

Abstract:

Link para artigo

Protective Adaptive Immunity Against Severe Acute Respiratory Syndrome Coronaviruses 2 (SARS-CoV-2) and Implications for Vaccines

Manners C, Larios Bautista E, Sidoti H, Lopez OJ.

Abstract:

Link para artigo

Pharmacologicaltreatment of COVID-19: lights and shadows

Menzella F, Biava M, Barbieri C, Livrieri F, Facciolongo N.

Abstract:

Link para artigo

The online competition between pro- and anti-vaccination views

Johnson NF, Vel√°squez N, Restrepo NJ, Leahy R, Gabriel N, El Oud S, Zheng M, Manrique P, Wuchty S, Lupu Y.

Abstract:

Link para artigo

COVID-19 vaccines: neutralizing antibodies and the alum advantage

Hotez PJ, Corry DB, Strych U, Bottazzi ME.

Abstract:

Link para artigo

NSAIDs for analgesia in the era of COVID-19

Herzberg DL, Sukumaran HP, Viscusi E.

Abstract:

Link para artigo

Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19

Palanques-Pastor T, López-Briz E, Poveda Andrés JL.

Abstract:

Link para artigo

Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series

Janowitz T, Gablenz E, Pattinson D, Wang TC, Conigliaro J, Tracey K, Tuveson D.

Abstract:

Link para artigo

Even covid-19 can't kill the anti-vaccination movement

Megget K.

Abstract:

Link para artigo

Covid-19 Pandemic and Current Medical Interventions

Manhas S, Anjali A, Mansoor S, Sharma V, Ahmad A, Rehman MU, Ahmad P.

Abstract:

Link para artigo

Immunotherapies for COVID-19: Restoring the immunity could be the priority

Allaouchiche B.

Abstract:

Link para artigo

Drug Repurposing for COVID-19: Ethical Considerations and Roadmaps

Ino H, Nakazawa E, Akabayashi A.

Abstract:

Link para artigo

SARS-CoV-2 (COVID-19) Vaccine Development and Production: An Ethical Way Forward

Iserson KV.

Abstract:

Link para artigo

Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19)

Chang FY, Chen HC, Chen PJ, Ho MS, Hsieh SL, Lin JC, Liu FT, Sytwu HK.

Abstract:

Link para artigo

Anti-Infectious Plants of The Thai Karen: A Meta-Analysis

Phumthum M, Balslev H.

Abstract:

Link para artigo

Pandemic Best Regulatory Practices: An Urgent Need in the Covid-19 Pandemic

Lumpkin MM, Lim JC.

Abstract:

Link para artigo

Mass intake of hydroxychloroquine or chloroquine in the present context of the Covid-19 outbreak: Possible consequences in endemic malaria settings

Mvumbi DM.

Abstract:

Link para artigo

Immunopharmacological management of COVID-19: Potential therapeutic role of valproic acid

Unal G, Turan B, Balcioglu YH.

Abstract:

Link para artigo

Combination of thrombolytic and immunosuppressive therapy for coronavirus disease 2019: A case report

Papamichalis P, Papadogoulas A, Katsiafylloudis P, Skoura AL, Papamichalis M, Neou E, Papadopoulos D, Karagiannis S, Zafeiridis T, Babalis D, Komnos A.

Abstract:

Link para artigo

A pharmacological interactome between COVID-19 patient samples and human sensory neurons reveals potential drivers of neurogenic pulmonary dysfunction

Ray PR, Wangzhou A, Ghneim N, Yousuf MS, Paige C, Tavares-Ferreira D, Mwirigi JM, Shiers S, Sankaranarayanan I, McFarland AJ, Neerukonda SV, Davidson S, Dussor G, Burton MD, Price TJ.

Abstract:

Link para artigo

Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements

Pandey A, Nikam AN, Shreya AB, Mutalik SP, Gopalan D, Kulkarni S, Padya BS, Fernandes G, Mutalik S, Prassl R.

Abstract:

Link para artigo

Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19

Dalamaga M, Karampela I, Mantzoros CS.

Abstract:

Link para artigo

On setting expectations for a SARS-CoV-2 Vaccine

Canaday DH, Gravenstein S.

Abstract:

Link para artigo

A case report of serious haemolysis in a glucose-6-phosphate dehydrogenase-deficient COVID-19 patient receiving hydroxychloroquine

Maillart E, Leemans S, Van Noten H, Vandergraesen T, Mahadeb B, Salaouatchi MT, De Bels D, Clevenbergh P.

Abstract:

Link para artigo

Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19

Sun J, Chen Y, Fan X, Wang X, Han Q, Liu Z.

Abstract:

Link para artigo

SARS-CoV-2 and COVID-19: between pathophysiology complexity and therapeutic uncertainty

Romagnoli S, Peris A, de Gaudio AR, Geppetti P.

Abstract:

Link para artigo

Why G6PD Deficiency Should Be Screened Before COVID-19 Treatment With Hydroxychloroquine?

Oymak Y, Karapinar TH, Devrim İ.

Abstract:

Link para artigo

Effects of Corticosteroid Treatment for Non-Severe COVID-19 Pneumonia: A Propensity Score-Based Analysis

Yuan M, Xu X, Xia D, Tao Z, Yin W, Tan W, Hu Y, Song C.

Abstract:

Link para artigo

Impact of nonpharmacological interventions on COVID-19 transmission dynamics in India

Patel P, Athotra A, Vaisakh TP, Dikid T, Jain SK; NCDC COVID Incident Management Team.

Abstract:

Link para artigo

Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?

Nina PB, Dash AP.

Abstract:

Link para artigo

Potential pharmacological agents for COVID-19

Kotwani A, Gandra S.

Abstract:

Link para artigo

COVID-19 vaccine development and the way forward

Arora NK, Das MK.

Abstract:

Link para artigo

Combination antiviral therapy with lopinavir/ritonavir, arbidol and interferon-α1b for COVID-19

Xie X, Jiang Y, Zeng Y, Liu H.

Abstract:

Link para artigo

Probiotics and COVID-19: is there any link?

Akour A.

Abstract:

Link para artigo

Does amantadine have a protective effect against COVID-19?

Cortés Borra A.

Abstract:

Link para artigo

COVID-19: a conundrum to decipher

Deshmukh V, Tripathi SC, Pandey A, Deshmukh V, Vykoukal J, Patil A, Sontakke B.

Abstract:

Link para artigo

An update on novel COVID-19 pandemic: a battle between humans and virus

Prajapati S, Sharma M, Kumar A, Gupta P, Narasimha Kumar GV.

Abstract:

Link para artigo

Is visiting Qom spread CoVID-19 epidemic in the Middle East?

Al-Rousan N, Al-Najjar H.

Abstract:

Link para artigo

Representation of specialties in Coronavirus Disease 2019 (COVID-19) research: analysis of published literature in the first 3 months

Robles J, Aggarwal G, Aggarwal S.

Abstract:

Link para artigo

Clinical characteristics of two human-to-human transmitted coronaviruses: Corona Virus Disease 2019 vs. Middle East Respiratory Syndrome Coronavirus

Xu P, Sun GD, Li ZZ.

Abstract:

Link para artigo

Viral kinetics and factors associated with rapid viral clearance during lopinavir/ritonavir-based combination therapy in non-severe COVID-19 patients

Ding JG, Li J, Hong L, Yu XQ, Ye EL, Sun GQ, Zhang XX, Chen L, Sun QF.

Abstract:

Link para artigo

Tocilizumab in the treatment of a critical COVID-19 patient: a case report

Wang L, Peng X, Wang ZH, Cai J, Zhou FC.

Abstract:

Link para artigo

Standardized out-patient diagnosis and treatment process for osteoporosis clinics during the COVID-19 pandemic

Zou J, Song DW, Niu JJ, Shi JW, Yang HL.

Abstract:

Link para artigo

No infectious risk of COVID-19 patients with long-term fecal 2019-nCoV nucleic acid positive

Wang QX, Huang KC, Qi L, Zeng XH, Zheng SL.

Abstract:

Link para artigo

Severe acute dried gangrene in COVID-19 infection: a case report

Novara E, Molinaro E, Benedetti I, Bonometti R, Lauritano EC, Boverio R.

Abstract:

Link para artigo

The impact of heroin illicit market in the framework of COVID 19 pandemic

Marinelli E.

Abstract:

Link para artigo

Gender differences in COVID-19 infection. The estrogen effect on upper and lower airways. Can it help to figure out a treatment?

Di Stadio A, Della Volpe A, Ralli M, Ricci G.

Abstract:

Link para artigo

Editorial - Sofosbuvir/Velpatasvir as a combination with strong potential activity against SARS-CoV2 (COVID-19) infection: how to use direct-acting antivirals as broad-spectrum antiviral agents

Izzi A, Messina V, Rinaldi L, Maggi P.

Abstract:

Link para artigo

Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents

Ayaz S, Crea F.

Abstract:

Link para artigo

[Suggestions on design of evidence-based traditional Chinese medicine clinical study for new public health emergencies]

Wang LX, Xie YM.

Abstract:

Link para artigo

[Ethical review of clinical study on intervention with traditional Chinese medicine in new public health emergencies]

Gu H, Wang ZF, Xie YM.

Abstract:

Link para artigo

[Pharmacovigilance study on drug-induced cardiac injury during treatment of COVID-19]

Zhang D, Lyu JT, Zhang B, Zhang XM, Lin ZJ.

Abstract:

Link para artigo

[TCMATCOV--a bioinformatics platform to predict efficacy of TCM against COVID-19]

Guo FF, Zhang YQ, Tang SH, Tang X, Xu H, Liu ZY, Huo RL, Li D, Yang HJ.

Abstract:

Link para artigo

[Mechanism of Xuanfei Baidu Tang in treatment of COVID-19 based on network pharmacology]

Wang Y, Li X, Zhang JH, Xue R, Qian JY, Zhang XH, Zhang H, Liu QQ, Fan XH, Cheng YY, Zhang BL.

Abstract:

Link para artigo

[Analysis of 131 cases of COVID-19 treated with Ganlu Xiaodu Decoction]

Chen L, Cheng ZQ, Liu F, Xia Y, Chen YG.

Abstract:

Link para artigo

[Clinical efficacy of Matrine and Sodium Chloride Injection in treatment of 40 cases of COVID-19]

Yang MW, Chen F, Zhu DJ, Li JZ, Zhu JL, Zeng W, Qu SL, Zhang Y.

Abstract:

Link para artigo

Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy?

Ibáñez S, Martínez O, Valenzuela F, Silva F, Valenzuela O.

Abstract:

Link para artigo

A New Drug-Drug Interaction Between Hydroxychloroquine and Metformin? A Signal Detection Study

Montastruc JL, Toutain PL.

Abstract:

Link para artigo

Novel therapeutic approaches for treatment of COVID-19

Hossein-Khannazer N, Shokoohian B, Shpichka A, Aghdaei HA, Timashev P, Vosough M.

Abstract:

Link para artigo

Mild COVID-19 symptoms despite treatment with teriflunomide and high-dose methylprednisolone due to multiple sclerosis relapse

Möhn N, Saker F, Bonda V, Respondek G, Bachmann M, Stoll M, Wattjes MP, Stangel M, Skripuletz T.

Abstract:

Link para artigo

Vaccines and Drug Therapeutics to Lock Down Novel Coronavirus Disease 2019 (COVID-19): A Systematic Review of Clinical Trials

Bhagavathula AS, Aldhaleei WA, Rovetta A, Rahmani J.

Abstract:

Link para artigo

Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARSCoV-2 and other acute viral infections: a systematic review and meta-analysis

Liu W, Zhou P, Chen K, Ye Z, Liu F, Li X, He N, Wu Z, Zhang Q, Gong X, Tang Q, Du X, Ying Y, Xu X, Zhang Y, Liu J, Li Y, Shen N, Couban RJ, Ibrahim QI, Guyatt G, Zhai S.

Abstract:

Link para artigo

SGLT-2 inhibitors for COVID-19 - A miracle waiting to happen or just another beat around the bush?

Chatterjee S.

Abstract:

Link para artigo

A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial

Rilinger J, Kern WV, Duerschmied D, Supady A, Bode C, Staudacher DL, Wengenmayer T.

Abstract:

Link para artigo

Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial

Cuadrado-Lavín A, Olmos JM, Cifrian JM, Gimenez T, Gandarillas MA, García-Saiz M, Rebollo MH, Martínez-Taboada V, López-Hoyos M, Fariñas MC, Crespo J.

Abstract:

Link para artigo

Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial

Barnabas RV, Brown E, Bershteyn A, Miller RS, Wener M, Celum C, Wald A, Chu H, Wesche D, Baeten JM; Hydroxychloroquine COVID-19 PEP Study Team.

Abstract:

Link para artigo

A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial

García IG, Rodriguez-Rubio M, Mariblanca AR, de Soto LM, García LD, Villatoro JM, Parada JQ, Meseguer ES, Rosales MJ, González J, Arribas JR, Carcas AJ, de la Oliva P, Borobia AM.

Abstract:

Link para artigo

Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial

Gorman E, Shankar-Hari M, Hopkins P, Tunnicliffe WS, Perkins GD, Silversides J, McGuigan P, Jackson C, Boyle R, McFerran J, McDowell C, Campbell C, McFarland M, Smythe J, Thompson J, Williams B, Curley G, Laffey JG, Clarke M, O'Kane C, McAuley DF.

Abstract:

Link para artigo

Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial

Irvani SSN, Golmohammadi M, Pourhoseingholi MA, Shokouhi S, Darazam IA.

Abstract:

Link para artigo

Umbilical cord blood therapy to prevent progression of COVID-19 related pneumonia: a structured summary of a study protocol for a pilot randomised controlled trial

Malhotra A, Ernest D, Rogers BA, Haylock D, Watt A, Moeneclaey G, Jenkin G.

Abstract:

Link para artigo

Effect of hydroxychloroquine on prevention of COVID-19 virus infection among healthcare professionals: a structured summary of a study protocol for a randomised controlled trial

Pirjani R, Soori T, Dehpour AR, Sepidarkish M, Moini A, Shizarpour A, Jafari RM.

Abstract:

Link para artigo

Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial

Maes B, Bosteels C, De Leeuw E, Declercq J, Van Damme K, Delporte A, Demeyere B, Vermeersch S, Vuylsteke M, Willaert J, Bollé L, Vanbiervliet Y, Decuypere J, Libeer F, Vandecasteele S, Peene I, Lambrecht B.

Abstract:

Link para artigo

Letter to the Editor: Repurposing of an Antisepsis Drug in COVID-19 Patients

Kumar A, Pareek V, Kant K.

Abstract:

Link para artigo

Vitamin D Supplementation in Influenza and COVID-19 Infections Comment on: "Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths" Nutrients 2020, 12(4), 988

Kow CS, Hadi MA, Hasan SS.

Abstract:

Link para artigo

Reply: "Vitamin D Supplementation in Influenza and COVID-19 Infections. Comment on: Evidence That Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths Nutrients 2020, 12(4), 988"

Grant WB, Baggerly CA, Lahore H.

Abstract:

Link para artigo

The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast

Almerie MQ, Kerrigan DD.

Abstract:

Link para artigo

Is the anti-filarial drug diethylcarbamazine useful to treat COVID-19?

Abeygunasekera A, Jayasinghe S.

Abstract:

Link para artigo

Treating COVID-19 with colchicine in community healthcare setting

Della-Torre E, Della-Torre F, Kusanovic Pcp M, Scotti R, Alvise-Ramirez G, Dagna L, Tresoldi M.

Abstract:

Link para artigo

Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19

Sempowski GD, Saunders KO, Acharya P, Wiehe KJ, Haynes BF.

Abstract:

Link para artigo

Rationale and Design of ORCHID: A Randomized Placebo-Controlled Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19

Casey JD, Johnson NJ, Semler MW, Collins SP, Aggarwal NR, Brower RG, Chang SY, Eppensteiner J, Filbin M, Gibbs KW, Ginde AA, Gong MN, Harrell F, Hayden DL, Hough CL, Khan A, Leither LM, Moss M, Oldmixon CF, Park PK, Reineck LA, Ringwood NJ, Robinson BR, Schoenfeld DA, Shapiro NI, Steingrub JS, Torr DK, Weissman A, Lindsell CJ, Rice TW, Thompson BT, Brown SM, Self WH; ORCHID Protocol Committee and the National Heart, Lung and Blood Institute Prevention and Early Treatment of Acute Lung Injury (PE

Abstract:

Link para artigo

Preparing for COVID-19 Related Drug Shortages

Shuman AG, Fox E, Unguru Y.

Abstract:

Link para artigo

Audio Interview: Diagnosis and Early Treatment of Covid-19

Rubin EJ, Baden LR, Morrissey S.

Abstract:

Link para artigo

Hydroxychloroquine for the Prevention of Covid-19 - Searching for Evidence

Cohen MS.

Abstract:

Link para artigo

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19

Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC, Skipper CP, Nascene AA, Nicol MR, Abassi M, Engen NW, Cheng MP, LaBar D, Lother SA, MacKenzie LJ, Drobot G, Marten N, Zarychanski R, Kelly LE, Schwartz IS, McDonald EG, Rajasingham R, Lee TC, Hullsiek KH.

Abstract:

Link para artigo

Lopinavir/ritonavir and interferon combination therapy may help shorten the duration of viral shedding in patients with COVID-19: a retrospective study in two designated hospitals in Anhui, China

Zuo Y, Liu Y, Zhong Q, Zhang K, Xu Y, Wang Z.

Abstract:

Link para artigo

Tocilizumab Administration in Patients with SARS-CoV-2 Infection: Subcutaneous Injection versus Intravenous Infusion

Shabani M, Shokouhi S, Moradi O, Saffaei A, Sahraei Z.

Abstract:

Link para artigo

COVID-19 patients benefit from early antiviral treatment: a comparative, retrospective study

Yu T, Tian C, Chu S, Zhou H, Zhang Z, Luo S, Hu D, Fan H.

Abstract:

Link para artigo

Remdesivir and Tocilizumab: Mix or Match

Akinosoglou K, Velissaris D, Ziazias D, Davoulos C, Tousis A, Tsiotsios K, Kalogeropoulou C, Spyridonidis A, Marangos M, Fligkou F, Gogos C.

Abstract:

Link para artigo

The case for why Africa should host COVID-19 candidate vaccine trials

Singh JA.

Abstract:

Link para artigo

A Randomized Trial of Convalescent Plasma for COVID-19-Potentially Hopeful Signals

Casadevall A, Joyner MJ, Pirofski LA.

Abstract:

Link para artigo

Outpatient Treatment at Home for Medicare Beneficiaries During and After the COVID-19 Pandemic

Bekelman JE, Emanuel EJ, Navathe AS.

Abstract:

Link para artigo

Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial

Li L, Zhang W, Hu Y, Tong X, Zheng S, Yang J, Kong Y, Ren L, Wei Q, Mei H, Hu C, Tao C, Yang R, Wang J, Yu Y, Guo Y, Wu X, Xu Z, Zeng L, Xiong N, Chen L, Wang J, Man N, Liu Y, Xu H, Deng E, Zhang X, Li C, Wang C, Su S, Zhang L, Wang J, Wu Y, Liu Z.

Abstract:

Link para artigo

Feasibility of a Pilot Program for COVID-19 Convalescent Plasma Collection in Wuhan, China

Li L, Yang R, Wang J, Lv Q, Ren M, Zhao L, Chen H, Xu H, Xie S, Xie J, Lin H, Li W, Fang P, Gong L, Gao X, Wang L, Wu Y, Liu Z.

Abstract:

Link para artigo

Does Vitamin D play a role in the management of Covid-19 in Brazil?

Ribeiro H, Santana KVS, Oliver SL, Rondó PHC, Mendes MM, Charlton K, Lanham-New S.

Abstract:

Link para artigo

Is there a rationale for heparin use among severe COVID-19 patients?

Savioli F.

Abstract:

Link para artigo

Targeting SARS-CoV-2 Receptors as a Means for Reducing Infectivity and Improving Antiviral and Immune Response: An Algorithm-based Method For Overcoming Resistance To Antiviral Agents

Gelman R, Bayatra A, Kessler A, Schwartz A, Ilan Y.

Abstract:

Link para artigo

HyPE study: hydroxychloroquine prophylaxis-related adverse events' analysis among healthcare workers during COVID-19 pandemic: a rising public health concern

Nagaraja BS, Ramesh KN, Dhar D, Mondal MS, Dey T, Saha S, Khan MA, Rutul SD, Pratik K, Manjula J, Sangeeth TA, Singh V.

Abstract:

Link para artigo

Mesenchymal Stem Cells for Coronavirus (COVID-19)-Induced Pneumonia: Revisiting the Paracrine Hypothesis with New Hopes?

Öztürk S, Elçin AE, Elçin YM.

Abstract:

Link para artigo

Adipose Stem Cells (ASCs) and Stromal Vascular Fraction (SVF) as a Potential Therapy in Combating (COVID-19)-Disease

Gentile P, Sterodimas A.

Abstract:

Link para artigo

Simultaneous Treatment of COVID-19 With Serine Protease Inhibitor Camostat and/or Cathepsin L Inhibitor?

Bittmann S, Weissenstein A, Villalon G, Moschuring-Alieva E, Luchter E.

Abstract:

Link para artigo

Clinical trials for coronavirus disease 2019: What is being evaluated and what is not

Arabi YM, Asseri A, Webb S, Marshall J, Al Moamary MS.

Abstract:

Link para artigo

[Treatment of COVID-19 guided by holistic view of traditional Chinese medicine--therapy aimed at both viral and host]

Yuan R, Xin QQ, Tang SH, Cong WH.

Abstract:

Link para artigo

[Recent advances in treatment of viral pneumonia using Chinese patent medicine]

Wang T, Han LF, Wang YF, Miao L, Yang J, Zhang JH, Gao XM, Zhang BL.

Abstract:

Link para artigo

[Exploration on scientific connotation of TCM syndromes and recommended prescriptions against COVID-19 based on TCMTP V2.0]

Xu HY, Zhang YQ, Qing YW, Zhao HY, Wang P, Liu F.

Abstract:

Link para artigo

[Discovery of intervention effect of Chinese herbal formulas on COVID-19 pulmonary fibrosis treated by VEGFR and FGFR inhibitors]

Bian YQ, Ma J, Ren Y, Zhang YL, Qiao YJ.

Abstract:

Link para artigo

[Therapeutic effect of Compound Qinlan Oral Liquid on treating combining disease with syndrome of human coronavirus pneumonia with pestilence attacking lung syndrome]

Bao YY, Shi YJ, Guo SS, Geng ZH, Bao L, Sun J, Zhao RH, Gao YJ, Fang TH, Meng J, Cui XL.

Abstract:

Link para artigo

Can concomitant use of zinc and curcumin with other immunity-boosting nutraceuticals be the arsenal against COVID-19?

Roy A, Sarkar B, Celik C, Ghosh A, Basu U, Jana M, Jana A, Gencay A, Sezgin GC, Ildiz N, Dam P, Mandal AK, Ocsoy I.

Abstract:

Link para artigo

Applied Clinical Pharmacology in a Crisis - Interleukin-6 Axis Blockade and COVID-19

Strohbehn GW, Reid PD, Ratain MJ.

Abstract:

Link para artigo

The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin

Chorin E, Dai M, Shulman E, Wadhwani L, Bar-Cohen R, Barbhaiya C, Aizer A, Holmes D, Bernstein S, Spinelli M, Park DS, Chinitz LA, Jankelson L.

Abstract:

Link para artigo

Antimicrobial use, drug-resistant infections and COVID-19

Rawson TM, Ming D, Ahmad R, Moore LSP, Holmes AH.

Abstract:

Link para artigo

Covid-19: 146 researchers raise concerns over chloroquine study that halted WHO trial

Mahase E.

Abstract:

Link para artigo

Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis

Çınar OE, Sayınalp B, Aladağ Karakulak E, Avşar Karataş A, Velet M, İnkaya AÇ, Ersoy Ortaç NE, Öcal S, Aksu S, Haznedaroğlu İC, Sayınalp N, Özcebe Oİ.

Abstract:

Link para artigo

Effect of Nonpharmaceutical Interventions on Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, South Korea, 2020

Ryu S, Ali ST, Jang C, Kim B, Cowling BJ.

Abstract:

Link para artigo

Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure?

Cour M, Ovize M, Argaud L.

Abstract:

Link para artigo

What we are talking about when we talk of steroid in COVID-19?

Rossato M.

Abstract:

Link para artigo

[Guide for the prevention and treatment of coronavirus disease 2019]

Chinese Thoracic Society; Chinese Association of Chest Physicians.

Abstract:

Link para artigo

Nicotinamide Riboside-The Current State of Research and Therapeutic Uses

Mehmel M, Jovanović N, Spitz U.

Abstract:

Link para artigo

Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks

Boccanegra B, Verhaart IEC, Cappellari O, Vroom E, De Luca A.

Abstract:

Link para artigo

Hydroxychloroquine-azithromycin for COVID-19 - Warranted or dangerous?

Popescu CP, Fischer PR.

Abstract:

Link para artigo

Pentoxifylline and complicated COVID-19: A pathophysiologically based treatment proposal

Assimakopoulos SF, Seintis F, Marangos M.

Abstract:

Link para artigo

The endosomal lipid bis(monoacylglycero) phosphate as a potential key player in the mechanism of action of chloroquine against SARS-COV-2 and other enveloped viruses hijacking the endocytic pathway

Carrière F, Longhi S, Record M.

Abstract:

Link para artigo

Current Perspective of Antiviral Strategies against COVID-19

Ahidjo BA, Loe M, Ng YL, Mok CK, Chu JJH.

Abstract:

Link para artigo

Incidence and Determinants of QT Interval Prolongation in COVID-19 Patients Treated with Hydroxychloroquine and Azithromycin

Maraj I, Hummel JP, Taoutel R, Chamoun R, Workman V, Li C, Tran L, DelVecchio A, Howes C, Akar JG.

Abstract:

Link para artigo

''Tociluzumab challenge: A series of cytokine storm therapy experience in hospitalized Covid-19 pneumonia patients''

Borku Uysal B, Ikitimur H, Yavuzer S, Ikitimur B, Uysal H, Islamoglu MS, Ozcan E, Aktepe E, Yavuzer H, Cengiz M.

Abstract:

Link para artigo

Feasibility of Tocilizumab in ICU patients with COVID-19

Issa N, Dumery M, Guisset O, Mourissoux G, Bonnet F, Camou F.

Abstract:

Link para artigo

Oncology Treatment in the Era of COVID-19: We Cannot Afford to Hit the Pause Button

Holstein SA, Vose JM.

Abstract:

Link para artigo

Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19

Eastman RT, Roth JS, Brimacombe KR, Simeonov A, Shen M, Patnaik S, Hall MD.

Abstract:

Link para artigo

Treatment of severe pneumonia due to COVID-19 with peginterferon alfa 2a

El-Lababidi RM, Mooty M, Bonilla MF, Salem NM.

Abstract:

Link para artigo

Characteristics of registered studies for Coronavirus disease 2019 (COVID-19): A systematic review

Yang M, Shang YX, Tian ZY, Xiong M, Lu CL, Jiang Y, Zhang Y, Zhang YY, Jin XY, Jin QB, Zhang Y, Willcox ML, Liu JP.

Abstract:

Link para artigo

Optimizing use of theranostic nanoparticles as a life-saving strategy for treating COVID-19 patients

Itani R, Tobaiqy M, Al Faraj A.

Abstract:

Link para artigo

The potential insights of Traditional Chinese Medicine on treatment of COVID-19

Tong T, Wu YQ, Ni WJ, Shen AZ, Liu S.

Abstract:

Link para artigo

Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study

Campochiaro C, Della-Torre E, Cavalli G, De Luca G, Ripa M, Boffini N, Tomelleri A, Baldissera E, Rovere-Querini P, Ruggeri A, Monti G, De Cobelli F, Zangrillo A, Tresoldi M, Castagna A, Dagna L; TOCI-RAF Study Group.

Abstract:

Link para artigo

Consensus statement. Corticosteroid therapy in ENT in the context of the COVID-19 pandemic

Herman P, Vincent C, Parietti Winkler C, Loundon N, Couloigner V, Tankere F, Tringali S, Gallet P, Papon JF, Montava M, Lavieille JP, Charpiot A, Schmerber S.

Abstract:

Link para artigo

Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19

Saha A, Sharma AR, Bhattacharya M, Sharma G, Lee SS, Chakraborty C.

Abstract:

Link para artigo

NLR: A Cost-effective Nomogram to Guide Therapeutic Interventions in COVID-19

Kerboua KE.

Abstract:

Link para artigo

Therapeutic efficacy of Qingfei Paidu decoction combined with antiviral drugs in the treatment of corona virus disease 2019: A protocol for systematic review and meta analysis

Gao K, Song YP, Chen H, Zhao LT, Ma L.

Abstract:

Link para artigo

Efficacy and safety of acupuncture therapy for COVID-19: A protocol for systematic review and meta-analysis

Huang S, Wang S, Wang M, Rong J, Yu W, Li J, Han J, Yang D.

Abstract:

Link para artigo

Efficacy and safety of Chinese herbal medicine for Coronavirus disease 2019: A protocol for systematic review and meta-analysis

Yang M, Hu Z, Yue R.

Abstract:

Link para artigo

Are type 1 interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19?

Gemcioglu E, Davutoglu M, Ozdemir EE, Erden A.

Abstract:

Link para artigo

Protective effects of vaccinations and endemic infections on COVID-19: A hypothesis

Meenakshisundaram R, Senthilkumaran S, Thirumalaikolundusubramanian P.

Abstract:

Link para artigo

Follow your Gut: Challenges in Nutritional Therapy during the COVID-19 Pandemic

Aguila EJT, Antoinette M, Francisco CPD.

Abstract:

Link para artigo

Erythropoiesis-Stimulating Agent Treatment in Patients With COVID-19

Fishbane S, Hirsch JS.

Abstract:

Link para artigo

Fatal arrhythmias: Another reason why doctors remain cautious about chloroquine/hydroxychloroquine for treating COVID-19

Uzelac I, Iravanian S, Ashikaga H, Bhatia NK, Herndon C, Kaboudian A, Gumbart JC, Cherry EM, Fenton FH.

Abstract:

Link para artigo

Lack of Antiviral Activity of Darunavir against SARS-CoV-2

De Meyer S, Bojkova D, Cinatl J, Van Damme E, Meng CB, Van Loock M, Woodfall B, Ciesek S.

Abstract:

Link para artigo

Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients with Inflammatory Bowel Disease

Lukin DJ, Kumar A, Hajifathalian K, Sharaiha RZ, Scherl EJ, Longman RS; JRC Study Group; WCM-GI Study Group.

Abstract:

Link para artigo

Impact of Anti-TNF and Thiopurines medications on the development of COVID-19 in patients with inflammatory bowel disease: A Nationwide VA cohort study

Khan N, Patel D, Xie D, Lewis J, Trivedi C, Yang YX.

Abstract:

Link para artigo

Successful use of methylprednisolone for treating severe COVID-19

Liu J, Zheng X, Huang Y, Shan H, Huang J.

Abstract:

Link para artigo

Mesenchymal Stem Cell-based Therapy for COVID-19: Possibility and Potential

Xiong J, Bao L, Qi H, Feng Z, Shi Y.

Abstract:

Link para artigo

Art therapy in the time of COVID-19

Braus M, Morton B.

Abstract:

Link para artigo

First case of drug-induced liver injury associated with the use of tocilizumab in a patient with COVID-19

Muhović D, Bojović J, Bulatović A, Vukčević B, Ratković M, Lazović R, Smolović B.

Abstract:

Link para artigo

Psoriasis, biologic therapy, and the pandemic of the 21st century

Nogueira M, Vender R, Torres T.

Abstract:

Link para artigo

Implications of COVID-19 Outbreak on Immune Therapies in Multiple Sclerosis Patients-Lessons Learned From SARS and MERS

Möhn N, Pul R, Kleinschnitz C, Prüss H, Witte T, Stangel M, Skripuletz T.

Abstract:

Link para artigo

Empirical Treatment and Prevention of COVID-19

Shin HS.

Abstract:

Link para artigo

Tocilizumab therapy in five solid and composite tissue transplant recipients with early ARDS due to SARS-CoV-2

Morillas JA, Marco Canosa F, Srinivas P, Asadi T, Calabrese C, Rajendram P, Budev M, Poggio ED, Narayanan Menon KV, Gastman B, Koval C.

Abstract:

Link para artigo

COVID-19: Stay Cool toward Corticosteroids

Fujishima S.

Abstract:

Link para artigo

Patients with systemic lupus erythematosus using hydroxychloroquine or chloroquine develop severe COVID-19 at similar frequency as patients not on antimalarials: need to explore antithrombotic benefits for COVID-19 coagulopathy. Response to: 'Clinical course of COVID-19 in patients with systemic

Konig MF, Gianfrancesco M, Yazdany J, Robinson PC.

Abstract:

Link para artigo

No advice to discontinue antirheumatic therapy for non-medical reasons in light of SARS-CoV-2. Response to: 'Treatment adherence of patients with sytemic rheumatic diseases in COVID-19 pandemic' by Fragoulis et al

Schulze-Koops H, Krueger K, Specker C.

Abstract:

Link para artigo

Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine

Carbillon L, Benbara A, Boujenah J.

Abstract:

Link para artigo

Treatment adherence of patients with systemic rheumatic diseases in COVID-19 pandemic

Fragoulis GE, Evangelatos G, Arida A, Bournia VK, Fragiadaki K, Karamanakos A, Kravvariti E, Laskari K, Panopoulos S, Pappa M, Tektonidou MG, Sfikakis PP.

Abstract:

Link para artigo

Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases

Cheong DHJ, Tan DWS, Wong FWS, Tran T.

Abstract:

Link para artigo

Selecting the Most Appropriate Oncological Treatment for Patients with Renal Masses During the COVID-19 Pandemic: Recommendations from a Referral Center

Moschovas MC, Mazzone E, Puliatti S, Mottrie A, Patel V.

Abstract:

Link para artigo

Dexmedetomidine and worsening hypoxemia in the setting of COVID-19: A case report

Stockton J, Kyle-Sidell C.

Abstract:

Link para artigo

Measurement of hydroxychloroquine in blood from SLE patients using LC-HRMS-evaluation of whole blood, plasma, and serum as sample matrices

Carlsson H, Hjorton K, Abujrais S, Rönnblom L, Åkerfeldt T, Kultima K.

Abstract:

Link para artigo

Does lopinavir measure up in the treatment of Covid-19?

Doggrell SA.

Abstract:

Link para artigo

Rate of Patient-Driven Biologic Treatment Discontinuation During the COVID-19 Pandemic in 2 Academic Hospital Clinics at the University of Toronto

Georgakopoulos JR, Yeung J.

Abstract:

Link para artigo

Clinical efficacy, speed of improvement and safety of apremilast for the treatment of adult Psoriasis during COVID-19 pandemic

Melis D, Mugheddu C, Sanna S, Atzori L, Rongioletti F.

Abstract:

Link para artigo

Pharmacokinetics of Favipiravir in Critically Ill Patients with COVID-19

Irie K, Nakagawa A, Fujita H, Tamura R, Eto M, Ikesue H, Muroi N, Tomii K, Hashida T.

Abstract:

Link para artigo

An open label cluster randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19 (ARCHAIC) - Protocol publication

Weehuizen JM, Hoepelman AIM.

Abstract:

Link para artigo

Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment

Soy M, Keser G, Atagündüz P, Tabak F, Atagündüz I, Kayhan S.

Abstract:

Link para artigo

Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19?

Vakil-Gilani K, O'Rourke K.

Abstract:

Link para artigo

Potential of Arbidol for Post-exposure Prophylaxis of COVID-19 Transmission-A Preliminary Report of a Retrospective Cohort Study

Zhang JN, Wang WJ, Peng B, Peng W, Zhang YS, Wang YL, Wan Y, Chang J, Mao L, Miao XP, Li YN, Zhou YF, Hu B.

Abstract:

Link para artigo

Hydroxychloroquine and azithromycin as a treatment of COVID-19

Fanin A, Calegari J, Beverina A, Tiraboschi S; Gruppo di Autoformazione Metodologica (GrAM).

Abstract:

Link para artigo

Pharmacy services at a temporary COVID-19 hospital in Wuhan, China

Wu J, Shen B, Li D, Song W, Li J, Zhang M, Liu G, Zhou B.

Abstract:

Link para artigo

Dose Optimization of Hydroxychloroquine for COVID-19: Do Blood Concentrations Matter?

Ippolito MM, Flexner C.

Abstract:

Link para artigo

Risk of using hydroxychloroquine as a treatment of COVID-19

Alanagreh L, Alzoughool F, Atoum M.

Abstract:

Link para artigo

The rediscovery of hydroxychloroquine in allergic diseases in the COVID-19 era

Bonzano L, Cassone G, Tarallo L, Pellacani G.

Abstract:

Link para artigo

Corticosteroids and the hyper-inflammatory phase of the COVID-19 disease

Taboada M, Caruezo V, Naveira A, Atanassoff PG.

Abstract:

Link para artigo

Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: a multicenter observational study

Russo V, Di Maio M, Attena E, Silverio A, Scudiero F, Celentani D, Lodigiani C, Di Micco P.

Abstract:

Link para artigo

Estimation of RAAS-Inhibitor effect on the COVID-19 outcome: A Meta-analysis

Pirola CJ, Sookoian S.

Abstract:

Link para artigo

Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend

Peng HC, Hussin N, Nalliah S, Ooi WT, Tang XY, Zachariah S, Singh GPSJ, Rani RA, Perumal K, Kooi CW.

Abstract:

Link para artigo

Lopinavir/ritonavir use in Covid-19 infection: is it completely non-beneficial?

Owa AB, Owa OT.

Abstract:

Link para artigo

COVID-19: Transmission, Prevention, and Potential Therapeutic Opportunities

Lotfi M, Hamblin MR, Rezaei N.

Abstract:

Link para artigo

Crushing lopinavir-ritonavir tablets may decrease the efficacy of therapy in COVID-19 patients

Eljaaly K, Al-Tawfiq JA.

Abstract:

Link para artigo

Are there any association between COVID-19 severity and immunosuppressive therapy?

Hormati A, Ghadir MR, Zamani F, Khodadadi J, Khodadust F, Afifian M, Aminnejad R, Ahmadpour S.

Abstract:

Link para artigo

Hydroxychloroquine for Covid-19 - When the pandemic runs faster than research

Frigerio M.

Abstract:

Link para artigo

Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence

Roustit M, Guilhaumou R, Molimard M, Drici MD, Laporte S, Montastruc JL; French Society of Pharmacology and Therapeutics (SFPT).

Abstract:

Link para artigo

The starting line for COVID-19 vaccine development

Lee N, McGeer A.

Abstract:

Link para artigo

Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19

Sharun K, Dhama K, Patel SK, Pathak M, Tiwari R, Singh BR, Sah R, Bonilla-Aldana DK, Rodriguez-Morales AJ, Leblebicioglu H.

Abstract:

Link para artigo

Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research

Bikdeli B, Madhavan MV, Gupta A, Jimenez D, Burton JR, Der Nigoghossian C, Chuich T, Nouri SN, Dreyfus I, Driggin E, Sethi S, Sehgal K, Chatterjee S, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Bertoletti L, Giri J, Cushman M, Quéré I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Tafur AJ, Francese DP, Batra J, Falanga A, Clerkin KJ, Uriel N, Kirtane A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Leon MB, Ston

Abstract:

Link para artigo

Zinc Iodide in combination with Dimethyl Sulfoxide for treatment of SARS-CoV-2 and other viral infections

Hoang BX, Hoang HQ, Han B.

Abstract:

Link para artigo

A review of South Indian medicinal plant has the ability to combat against deadly viruses along with COVID-19?

Divya M, Vijayakumar S, Chen J, Vaseeharan B, Dur√°n-Lara EF.

Abstract:

Link para artigo

Angiotensin receptor blockers for the treatment of covid-19 and its comorbidities

Saavedra JM.

Abstract:

Link para artigo

Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system

Yuan S, Chan JFW, Chik KKH, Chan CCY, Tsang JOL, Liang R, Cao J, Tang K, Chen LL, Wen K, Cai JP, Ye ZW, Lu G, Chu H, Jin DY, Yuen KY.

Abstract:

Link para artigo

Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19

Klement-Frutos E, Burrel S, Peytavin G, Marot S, Lê MP, Godefroy N, Calvez V, Marcelin AG, Caumes E, Pourcher V, Boutolleau D.

Abstract:

Link para artigo

Death threats after a trial on chloroquine for COVID-19

Ektorp E.

Abstract:

Link para artigo

Treatment of COVID-19 Patients with Convalescent Plasma

Salazar E, Perez KK, Ashraf M, Chen J, Castillo B, Christensen PA, Eubank T, Bernard DW, Eagar TN, Long SW, Subedi S, Olsen RJ, Leveque C, Schwartz MR, Dey M, Chavez-East C, Rogers J, Shehabeldin A, Joseph D, Williams G, Thomas K, Masud F, Talley C, Dlouhy KG, Lopez BV, Hampton C, Lavinder J, Gollihar JD, Maranhao AC, Ippolito GC, Saavedra MO, Cantu CC, Yerramilli P, Pruitt L, Musser JM.

Abstract:

Link para artigo

Treatment of COVID-19 with pentoxifylline: Could it be a potential adjuvant therapy?

Seirafianpour F, Mozafarpoor S, Fattahi N, Sadeghzadeh-Bazargan A, Hanifiha M, Goodarzi A.

Abstract:

Link para artigo

Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial

Lê MP, Peiffer-Smadja N, Guedj J, Néant N, Mentré F, Ader F, Yazdanpanah Y, Peytavin G; C-20–15 DisCoVeRy French Steering Committee.

Abstract:

Link para artigo

Potential inhibition of COVID-19-driven pneumonia by immunosuppressive therapy and anti-TNFα antibodies: a case report

Kunisaki R, Tsukiji J, Kudo M.

Abstract:

Link para artigo

TPE-nAbs combination therapy for severe COVID-19

Malkovsky M.

Abstract:

Link para artigo

Age-dependent gender differences of COVID-19 in mainland China: comparative study

Qian J, Zhao L, Ye RZ, Li XJ, Liu YL.

Abstract:

Link para artigo

Assessing the impact of non-pharmaceutical interventions on SARS-CoV-2 transmission in Switzerland

Lemaitre JC, Perez-Saez J, Azman AS, Rinaldo A, Fellay J.

Abstract:

Link para artigo

COVID-19 pneumonia treated with Sarilumab: a clinical series of eight patients

Benucci M, Giannasi G, Cecchini P, Gobbi FL, Damiani A, Grossi V, Infantino M, Manfredi M.

Abstract:

Link para artigo

Why not to use colchicine in COVID-19? An old anti-inflammatory drug for a novel auto-inflammatory disease

Piantoni S, Patroni A, Toniati P, Furloni R, Franceschini F, Andreoli L, Scarsi M.

Abstract:

Link para artigo

Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome

Qu W, Wang Z, Hare JM, Bu G, Mallea JM, Pascual JM, Caplan AI, Kurtzberg J, Zubair AC, Kubrova E, Engelberg-Cook E, Nayfeh T, Shah VP, Hill JC, Wolf ME, Prokop LJ, Murad MH, Sanfilippo FP.

Abstract:

Link para artigo

Treatment algorithm for COVID-19: a multidisciplinary point of view

Galluccio F, Ergonenc T, Garcia Martos A, Allam AE, Pérez-Herrero M, Aguilar R, Emmi G, Spinicci M, Terrancle Juan I, Fajardo-Pérez M.

Abstract:

Link para artigo

Questions remain following first COVID-19 vaccine results

Sheridan C.

Abstract:

Link para artigo

Response to: Correspondence regarding research letter to the editor by Mathian et al, 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'' by Nikpour et al

Mathian A, Amoura Z.

Abstract:

Link para artigo

Correspondence regarding research letter to the editor by Mathian et al, 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'

Nikpour M, Teh B, Wicks IP, Pellegrini M.

Abstract:

Link para artigo

Covid-19: Doctors criticise Indian research agency for recommending hydroxychloroquine prophylaxis

Bmj India Correspondent.

Abstract:

Link para artigo

Epinephrine use in COVID-19: friend or foe?

Luo P, Liu D, Li J.

Abstract:

Link para artigo

Critical medication shortages further dwindling hospital resources during COVID-19

Farrell NM, Hayes BD, Linden JA.

Abstract:

Link para artigo

Silencing of immune activation with methotrexate in patients with COVID-19

Safavi F, Nath A.

Abstract:

Link para artigo

Pulmonary Delivery of Fenretinide: A Possible Adjuvant Treatment In COVID-19

Orienti I, Gentilomi GA, Farruggia G.

Abstract:

Link para artigo

Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?

Rossi F, Tortora C, Argenziano M, Di Paola A, Punzo F.

Abstract:

Link para artigo

Excess Ascorbate is a Chemical Stress Agent against Proteins and Cells

Lehene M, Fischer-Fodor E, Scurtu F, Hădade ND, Gal E, Mot AC, Matei A, Silaghi-Dumitrescu R.

Abstract:

Link para artigo

The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike

Li Y, Zhang Z, Yang L, Lian X, Xie Y, Li S, Xin S, Cao P, Lu J.

Abstract:

Link para artigo

Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-19

Hassoun A, Thottacherry ED, Muklewicz J, Aziz QU, Edwards J.

Abstract:

Link para artigo

Survival of COVID-19 patients requires precise immune regulation: The hypothetical immunoprotective role of nicotinic agonists

Allahverdi Khani M, SalehiRad M, Darbeheshti S, Motaghinejad M.

Abstract:

Link para artigo

Emerging pharmacotherapies for COVID-19

Salvi R, Patankar P.

Abstract:

Link para artigo

Three cases of treatment with Nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy

Jang S, Rhee JY.

Abstract:

Link para artigo

Successful recovery of severe COVID-19 with cytokine storm treating with extracorporeal blood purification

Wang Q, Hu Z.

Abstract:

Link para artigo

Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review

Rodrigo C, Fernando SD, Rajapakse S.

Abstract:

Link para artigo

Ramipril in High Risk Patients with COVID-19

Amat-Santos IJ, Santos-Martinez S, López-Otero D, Nombela-Franco L, Gutiérrez-Ibanes E, Del Valle R, Muñoz-García E, Jiménez-Diaz VA, Regueiro A, González-Ferreiro R, Benito T, Sanmartin-Pena XC, Catalá P, Rodríguez-Gabella T, Delgado-Arana JR, Carrasco-Moraleja M, Ibañez B, San Román JA.

Abstract:

Link para artigo

Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial

Cao Y, Wei J, Zou L, Jiang T, Wang G, Chen L, Huang L, Meng F, Huang L, Wang N, Zhou X, Luo H, Mao Z, Chen X, Xie J, Liu J, Cheng H, Zhao J, Huang G, Wang W, Zhou J.

Abstract:

Link para artigo

Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients

Liu T, Luo S, Libby P, Shi GP.

Abstract:

Link para artigo

Remdesivir and Potential Interactions With Psychotropic Medications: A COVID-19 Perspective

Mansuri Z, Shah B, Zafar MK, Jolly T, Jain S.

Abstract:

Link para artigo

Metformin use amid COVID-19 pandemic